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Abstract: A fast and effective wound healing process would substantially decrease medical 
costs, wound care supplies, and hospitalization significantly improving the patients’ quality 
of life. The search for effective therapeutic approaches seems to be imperative in order to 
avoid the aggravation of chronic wounds. In spite of all the efforts that have been made 
during the recent years towards the development of artificial wound dressings, none of the 
currently available options combine all the requirements necessary for quick and optimal 
cutaneous regeneration. Therefore, technological advances in the area of temporary and 
permanent smart dressings for wound care are required. The development of nanoscience 
and nanotechnology can improve the materials and designs used in topical wound care in 
order to efficiently release antimicrobial, anti-inflammatory and regenerative compounds 
speeding up the endogenous healing process. Nanostructured dressings can overcome the 
limitations of the current coverings and, separately, natural origin components can also 
overcome the drawbacks of current antibiotics and antiseptics (mainly cytotoxicity, 
antibiotic resistance, and allergies). The combination of natural origin components with 
demonstrated antibiotic, regenerative, or anti-inflammatory properties together with 
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nanostructured materials is a promising approach to fulfil all the requirements needed for the 
next generation of bioactive wound dressings. Microbially compromised wounds have been 
treated with different essential oils, honey, cationic peptides, aloe vera, plant extracts, and 
other natural origin occurring antimicrobial, anti-inflammatory, and regenerative components 
but the available evidence is limited and insufficient to be able to draw reliable conclusions 
and to extrapolate those findings to the clinical practice. The evidence and some promising 
preliminary results indicate that future comparative studies are justified but instead of talking 
about the beneficial or inert effects of those natural origin occurring materials, the scientific 
community leads towards the identification of the main active components involved and their 
mechanism of action during the corresponding healing, antimicrobial, or regenerative 
processes and in carrying out systematic and comparative controlled tests. Once those natural 
origin components have been identified and their efficacy validated through solid clinical 
trials, their combination within nanostructured dressings can open up new avenues in the 
fabrication of bioactive dressings with outstanding characteristics for wound care. The 
motivation of this work is to analyze the state of the art in the use of different essential oils, 
honey, cationic peptides, aloe vera, plant extracts, and other natural origin occurring 
materials as antimicrobial, anti-inflammatory and regenerative components with the aim of 
clarifying their potential clinical use in bioactive dressings. We conclude that, for those 
natural occurring materials, more clinical trials are needed to reach a sufficient level of 
evidence as therapeutic agents for wound healing management. 
Keywords: dressings; chronic wounds; nanostructured materials; electrospinning; honey; 
essential oils; tissue engineering; infection; inflammation; regeneration 
 
1. Introduction 
Human skin is the largest organ in our body. Adult skin comprises three different layers: the 
keratinized stratified epidermis, formed by the stratum corneum and by the underlying nucleated 
epidermis composed of four differentiated layers showing complex cell-cell interactions; the dermis 
which is a thick collagen-rich connective tissue where follicles, glands, nerves and capillary vessels are 
embedded; and the hypodermis which mainly consists of blood vessels and adipose tissue (Figure 1) [1–3]. 
It forms an effective barrier between the external environment and our organism protecting us from 
water loss and against pathogens and harmful assaults [4]. Its complexity comprises a wide number of 
interconnected constituents providing not only physical protection but also biochemical and adaptive 
immunity. Any change in these constituents results in the alteration of the barrier function, which can 
culminate in a potential damage [3,5]. 
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Figure 1. Schematic representation of human adult skin. Five different layers form the 
stratified epidermis: stratum corneum (a), stratum lucidum (b), stratum granulosum (c), 
stratum spinosum (d) to the stratum basal (e) [1]. (Copyright Karger Publishers 2015). 
This alteration or damage in the skin is of great importance as skin is our first protective barrier,  
so, a fast and efficient repair is imperative to avoid bacterial colonization, chronification, or even more 
severe injuries. When the wound healing machinery does not work properly, it is necessary to use a 
therapeutic treatment to speed up the natural process in order to avoid more serious pathologies and to 
improve the patients’ quality of life. These treatments can be as varied as the type of wound and as the 
part of the body to be healed, and constitute an enormous burden for any health care system. The search 
of cost-effective therapies for wound healing is becoming an essential topic of ongoing research and 
discussion worldwide. 
1.1. Wounds 
Skin wounds are described as disruptions in the normal anatomical structure of the tissue which lead 
to an abnormal behavior. One of the essential issues to study, diagnose, and treat a wound is its 
assessment. Wound assessment has different aspects but the most important is wound extent considering 
the extension of tissue damage and its severity. Skin wounds normally affect just the epidermis and 
dermis and are produced by internal or external forces. However, some wounds are or become deeper 
producing more severe outcomes including the hypodermis, fascia, muscle, tendon, bone and viscera, 
which are normally defined as ulcers [6,7]. 
In general terms, wounds may also be classified as acute and chronic wounds. Acute wounds are often 
produced by trauma (e.g., burns, lacerations, abrasions) and repair themselves in an organized and well 
timed process which results in the anatomic and physiologic re-establishment of the damaged skin [8]. 
On the contrary, chronic wounds fail time-wise, so a complete restoration of the skin structure and 
Materials 2015, 8 5157 
 
 
function is not successful in those cases [7,9]. Chronic wounds such as pressure ulcers are relatively 
common in long-term patients with reduced mobility, which may lead not only to skin damage but also 
to progressive injury into the muscle, tendon and bone, as well as to infection, septicaemia, osteomyelitis 
and, even death. Other ulcers, such as leg or venous ulcers, are also chronic wounds produced by venous 
hypertension or by failure in venous valves [9,10]. Foot ulcers and associated wounds are one of the 
most devastating complications of diabetes, often associated to injury and infections which may also 
lead to serious complications or even amputation due to the lack of sensitivity to injury, blister formation 
or cut [9]. Early detection is undoubtedly a key factor to avoid these complications together with an 
effective wound care. 
1.2. The Clinical Burden of Wounds in the Health Care System 
In the last decades, the increase in longevity, mainly in developed countries, due to medical 
breakthroughs and improved life quality, demonstrates a sign of progress, but also brings an increase in 
chronic health problems which, in several cases, implies the presence of non-healing wounds [11].  
The chronicity in wounds has become a serious problem not only due to the economic burden of their 
clinical care but also to the emotional costs for patients and their families [7]. 
Concerning the financial burden for health care systems, wound complications are linked to bed 
occupation in hospitals, nurse time spent in wound care, longer and more intensive treatments, and 
medical and surgical interventions [10]. In this regard, the Eucomed Advanced Wound Care Sector 
Group recommended in 2008 to the European Commission the support and promotion of research in 
wound treatment and prevention in the light of the four million annual wound incidences in Europe [12]. 
The Canadian Association of Wound Care has recently published very interesting data [13] pointing out 
to an average cost of C$ 10,376 for treating a chronic wound and C$ 11,840 for treating an acute wound 
without complications, 165 days being the average time to closure for the later. 
Pressure wounds have shown high prevalence in long-term patients in Europe (~20%) with the 
subsequent costs in pressure-redistributing equipment and additional nursing time. For example, it was 
estimated an annual burden of € 461 million in Spain in 2006 associated with those wounds, which 
represents the 5% of the total health-care spending, and, in 2009, it was estimated that the US spent US$ 11 
billion in the management of these types of wounds [14]. In addition, in 2008, leg and foot ulcers showed 
an estimated annual burden of € 10–12 billion to the European Union health care systems. Furthermore, 
it has been calculated that in Europe, in a hospital performing 10,000 operations annually, 3%–4% of 
the surgeries lead to an infected wound with an annual cost of about € 2 million [10]. 
Even though the true impact of wound care can only be estimated, the data summarized above clearly 
show the enormous economic burden of wound care. A more rapid and effective wound healing process 
would substantially decrease medical costs, wound care supplies and hospitalization, and would 
significantly improve the patients’ quality of life. 
1.3. Wound Healing Process: Stages of Wound Healing 
Healthy epithelium maintains its homeostasis due to a complicated balance between tissue injury and 
regeneration which is highly regulated by epithelial stem cells [15]. Wound healing is a highly complex 
dynamic process which goal is the total restoration of the skin structure and function [1,16], and consists 
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of three differentiated though overlapping phases: inflammation, proliferation, and tissue remodeling 
(Figures 2 and 3) [2,17,18].  
 
Figure 2. Normal wound healing stages with the main events involved. 
The inflammatory stage involves blood vessel injury, coagulation, and an acute local inflammatory 
response [6], with the recruitment of neutrophils, monocytes, macrophages, and lymphocytes as well as 
infiltration of leukocytes and subsequent secretion of inflammatory cytokines and growth factors [19]. 
In the proliferation phase, the cytokines and factors released in the previous stage stimulate the 
proliferation of progenitor cells, the recruitment of fibroblasts, keratinocytes, and endothelial cells, and 
finally cell migration and proliferation. As a consequence of these events, at this proliferative stage, 
granulation tissue is formed, angiogenesis induced and extracellular matrix (ECM) secreted [19–21]. 
The remodeling phase is characterized by the epithelial-mesenchymal transition (EMT) where cells 
migrate to re-epithelialize the damaged tissue in the edges of the wound. Then, wound contraction occurs 
and fibroblasts differentiate to myofibroblasts which results in scar-tissue formation [15]. As a consequence 
of the angiogenesis initiated in the previous stage, new blood vessels are generated followed by nerve 
sprouting [21]. 
 
Figure 3. Cont. 
  
Materials 2015, 8 5159 
 
 
 
Figure 3. Wound healing stages: inflammation (a), proliferation (b) and tissue remodeling (c). 
(a) Inflammation is characterized by blood vessel injury, coagulation, and acute local 
inflammatory response with the formation of the protective clot against microbial infections; 
(b) The proliferation phase involves cell migration, granulation tissue formation, and 
angiogenesis; (c) Tissue remodeling implies the formation of a disorganized ECM as is 
depicted in the picture as well as a slightly elevated area together with the lack of normal 
skin appendages [22]. (Copyright Nature Publishing Group 2008). 
Different factors may hinder those events including age, obesity, social causes, drugs or previous 
diseases [7,9,11,16,17,23]. Hypertrophic scars, which are the result of an excessive deposition of 
collagen, and non-healing (chronic) wounds are commonly present in the clinic [19]. Chronic wounds 
are frequently associated with a reduced number and well-defined pathologies, such as venous 
insufficiency, ischemia, diabetes mellitus, pressure necrosis, or vasculitis, which can affect healing at 
different stages. Several experimental clinical studies have clearly shown failure in the availability of 
growth factors to aid in the healing cascade because of insufficient production, defective release, 
trapping and/or increased degradation in those chronic cases [6,24]. On the other hand, angiogenesis 
may be insufficient due to previous pathologies [25–28]. 
However, not only previous diseases can hinder healing, the microenvironment of the wound may 
also play an important role. [16,18,19]. Bacterial components have been highlighted as harmful factors 
during wound healing due to their interference with cell-matrix interactions and due a reduced 
inflammatory response they produce [16,23,29,30]. As in other infective processes, bacteria can colonize 
wounds as a biofilm which is a complex aggregate of bacteria embedded in an ECM with the ability to 
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form a highly resistant impervious microenvironment against antibiotics while maintaining the inflammatory 
stage [31,32]. 
2. Solutions and Standard Care Guidelines 
2.1. Current Therapeutic Approaches/Options for Chronic Wound Treatment 
The effective treatment of chronic wounds should be aimed at identifying and resolving the potential 
etiologic factors responsible for the non-healing wound state, leading to an important impact on the final 
clinical outcome. Several clinical practice guidelines and established medical protocols used during 
wound management have been extensively described to promote greater uniformity of care and to 
improve treatment outcomes. In that sense, the Wound Bed Preparation (WBP) emerged in 2000 to 
systematize the treatment of chronic wounds. It was defined as the global wound management in order 
to accelerate endogenous healing or to facilitate the effectiveness of other therapeutic approaches [33]. 
In that way, an initial assessment of the wound together with the overall health status of the patient, to 
consider existing pathologies which might hamper the endogenous healing, are indispensable for 
implementing an adequate treatment programme [34]. In addition, an evaluation of the wound state and 
response to the treatment should be regularly done. 
After thorough evaluation of the patient and their wound, a local wound-care plan must be initiated. 
Consequently, the removal of devitalised tissue, a minimal amount of necrotic tissue, the maintenance 
of normal endogenous antimicrobial and proteolytic activity and an adequate control of inflammation 
and exudate are indispensable requirements for the progression of wound healing, and, therefore,  
the successful treatment of a complex wound. 
Numerous techniques are employed nowadays for wound debridement. The choice of this 
debridement method do not depend on the diagnosis of the wound but on the presence of certain tissues 
covering the wound as well as on particular factors related to the patient and wound situation [35]. 
Inflammation is a physiological response to wounding and is required for wound healing to progress. 
However, excessive or inappropriate inflammation provides an ideal environment for bacterial 
infiltration and proliferation and may cause serious health problems. So, the prolonged inflammation 
characterizing the chronic wounds is a promising target for therapeutic interventions [36,37].  
The recommended treatment for managing infection is a combined strategy to reduce the bacterial 
burden and to optimize the host response. In last years, there has been a renewed interest in the use of 
the antiseptics for the management of infected wounds due to the ongoing risk of allergies and resistance 
to topical and systemic antibiotics. The range of topical antiseptics agents currently used in the 
management of wound infection includes alcohols, acetic acid, chlorhexidine, honey, hydrogen 
peroxide, hypochlorous acid, potassium permanganate, polyhexamethyl biguanide (PHMB), products 
containing iodine (cadexomer iodine and povidone iodine) and products containing silver (silver 
sulfadiazine and silver-impregnated dressings). Dressings incorporating these antiseptics can 
successfully be used in topical management to reduce the load of a wide variety of pathogens [36–38]. 
Exudate production is a normal feature of healing wounds. However, when wounds produce 
insufficient or too much exudate, and/or the composition of the exudate is harmful, a wide range of 
problems can occur that ultimately delay healing, distress patients, and consume considerable healthcare 
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resources [39]. In local wound management, dressings are the main option for managing exudate, being 
employed to increase, maintain, or reduce wound moisture. The final phase of wound healing is the 
epithelialisation. Debridement, control of inflammation, and moisture are essential factors of wound bed 
preparation that may stimulate the edge of the wound to migrate, but if this systematic approach produces 
a well-vascularized healthy wound bed which still fails to heal, additional therapies may be required. [40,41]. 
Alternatively, in patients whose ability to heal is compromised and in situations where skin coverage 
is inadequate, advanced therapies like bioengineered skin substitutes can be used to replace either 
temporarily or permanently the form and function of the skin, promoting the healing of the wound [41–43]. 
Although, these products have some advantages such as their availability in large quantities and 
negligible risks of immunologic issues, the main limitation is their expense. Besides, they still rely 
heavily on optimal wound bed preparation. 
2.2. Wound Dressings 
2.2.1. Classification of Dressings: Passive, Interactive, and Bioactive Dressings 
As aforementioned, one of the main medical options for the treatment of chronic wounds is the use 
of appropriate topical dressings which play an important role for correcting the underlying causes of 
non-healing wounds and, therefore, to aid during the healing process. In some situations, dressings are 
used as the definitive treatment, whereas in others they perform an important adjunctive role, being an 
intermediate step for other treatments. 
Since ancient times, wound dressings have evolved from natural origin materials that simply covered 
and concealed the wound to modern materials specially designed to provide particular benefits. 
Numerous categories and classifications of wound dressings have been published. Wound dressings 
are generally classified into three broad groups based on their nature of action: inert/passive, interactive, 
and bioactive. For many years, the mainstay of wound management was simply to protect the wound 
and all therapeutic efforts focused on drying the wound site. For that, passive dressings which are 
ordinary dressings, such as gauze and tulle, merely were used to cover and conceal the wound while 
repairing underneath. In addition, these passive products, which have a minimal role in the healing 
process, prevented infection by forming a barrier against bacterial colonization. However, these 
dressings produce a waterproof cover over the wound and their use can lead to skin maceration around 
the wound since water vapour and exudation may not pass through becoming trapped within the wound [44]. 
This lack of vapour permeation results in dressing leakage and the need for frequent replacements. The 
pioneering idea to change the nature of wound dressing materials was the discovery of the critical role 
of moisture in wound healing proved by Winter in 1962 [45]. Moist wound healing refers to the provision 
and maintenance of optimal hydration of the exposed tissues in the wound, establishing and maintaining 
an optimal environment for wound repair. Thus, the newer dressings have been designed to establish and 
maintain an optimal environment for wound repair. Interactive dressings are capable of modifying the 
physiology of the wound environment and interact with the wound surface to optimize healing by 
promoting debridement, enhancing granulation and re-epithelialization, and reducing the exudate levels 
and bacterial colonization counts. Interactive products are mostly transparent, permeable to water vapor and 
oxygen and impermeable to bacteria [46–48]. Some of the products including in the category of interactive 
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dressings are hydrocolloids, alginates, collagen, hyaluronic acid (HA) products, foams, hydrogels,  
and semipermeable films. 
In spite of these dressings, many wounds still persist. In order to promote the healing in these complex 
wounds, numerous bioactive dressings have been developed. These products deliver active substances, 
such as antimicrobials and antibiotics, which have a direct role in changing the chemical and cellular 
environment of the local wound, stimulating the healing cascade [48,49]. 
2.2.2. Desirable Characteristics of Wound Dressings 
Nowadays, an ideal wound dressing material should have extraordinary properties which would 
enhance/improve the wound healing process including its ability for maintaining a moist wound 
environment, debridement of wound site, absorption of excess exudate and blood at wound site, free of 
particles and toxic wound contaminants, non-toxic and non-allergenic, allow an adequate gaseous 
exchange, capable of protecting the wound from further trauma, low adherence and ease of removal, 
infection prevention and bacterial invasion protection, thermal insulation, minimal frequency of dressing 
change, easy of application, long shelf-life, comfortable and conformable, and cost effectiveness [47,50,51]. 
However, in spite of all the efforts that have been made during the last years towards the development 
of artificial wound coverings, no currently available dressing combines all those previous requirements 
necessary for a quick and optimal cutaneous regeneration. Therefore, more technological advances in 
the area of temporary and permanent smart dressings for wound care are required. 
3. Materials 
3.1. Nanostructured Dressings 
Current efforts in tissue engineering are focused on the creation of three-dimensional scaffolds 
mimicking the ECM. However, when the tissue does not have its inherent potential to regenerate, the 
supply of only a scaffold to the defective site does not assure tissue repair. In that way, as an additional 
method of tuning the biomimetic artificial matrix, different biological molecules such as growth factors, 
angiogenic factors, cell surface receptors and antimicrobial, antibacterial, and anti-inflammatory agents 
can be easily incorporated into those scaffolds to improve cell behaviour as well as tissue regeneration. 
A wide range of nanoscale materials have been reported in the literature showing their successful 
application in tissue repair and wound management. Among all the nanoscale structures used to generate 
artificial ECM, nanofibrous scaffolds have been proposed as the most promising candidates (Figure 4) [52]. 
Several intrinsic properties of nanofibrous scaffolds, such as high surface area to volume ratio, sufficient 
mechanical stability and adequate pore size of the resulting nanofibrous matrix, make these materials 
particularly interesting for wound healing and drug-delivery applications. So, the high porosity of the 
nanofiber matrix allows oxygen and water permeability and nutrients exchange and also the removal of 
metabolic waste preventing fluid accumulation at the wound site. Furthermore, the high surface area 
favours cell attachment and subsequent proliferation and differentiation during tissue regeneration. 
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3.2. Scaffolds Based on Natural Origin and Synthetic Polymers 
The efficacy of these replacements is widely dependent on the choice of their construction materials, 
structures and physicochemical properties. Polymers have been widely used as biomaterials for the 
fabrication of tissue-engineering scaffolds. Thus, different forms of scaffolds such as films, gels, 
sponges, membranes, micro and nanofibers made of natural origin and synthetic polymers have been 
developed and evaluated as dermal substitutes to date. 
 
Figure 4. Scanning Electron Microscopy (SEM; a,b,d,e) and Transmission Electron 
Microscopy (TEM; c,f) micrographs of nanofibrous scaffolds, consisting of polylactic  
acid (PLLA)/polycaprolactone (PCL) (a,b) and chitosan (d,e) polymers, synthetized by 
electrospinning technique (unpublished results). 
3.2.1. Natural Origin Polymers 
Natural origin polymers have been widely used in regenerative medicine because of their 
biocompatibility, biodegradability, biological characteristics and structural similarities with human 
tissues. Naturally derived materials from animals or plants, which are usually constituted by proteins  
or polysaccharides, mimic the fibrillary structure of native ECM and have similar architectural 
resemblances [53,54]. 
Collagen is the major protein component of the ECM, and multiple scaffolds based on this material 
have been described as building material in many biomedical applications including wound dressings. 
For example, collagen-minocycline based hydrogels are potentially applicable for the treatment of 
cutaneous wound infections [55], denatured collagen microfiber scaffolds seeded with human fibroblasts 
and keratinocytes can be used as skin grafts [56], collagen-alginic acid can also be used as wound 
dressing materials [57], electrospun collagen nanofibrous scaffolds have been also applied in wound 
repair [58]. In that regard, Powell et al. [59] compared collagen nanofibrous scaffolds produced by freeze 
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drying and electrospinning methods as skin substitutes demonstrating that although both scaffolds can 
be used to fabricate skin substitutes with optimal cellular organization, proliferation and maturation, 
electrospun scaffolds can potentially reduce wound contraction much faster compared to the freeze-dried 
ones. Currently, Biobrane®, Integra®, Apligraf®, and Transcyte® are available as commercial biological 
skin substitutes based on collagen and are widely used in wound healing [60,61]. 
Gelatin, a natural origin polymer derived from collagen, has also been used in medical applications, 
especially in the production of biocompatible and biodegradable wound dressings. The optimal 
morphology of an electrospun gelatin scaffold for skin repair was studied by Powel and Boyce [62] 
demonstrating that, principally, porosity and interfiber distance play a significant factor in tissue 
morphogenesis. More recently, Bilgic et al. [63] demonstrated that gelatin-based biodegradable scaffolds 
have an enormous potential to enhance wound healing. 
Fibrin, a complex network naturally formed by fibrinogen polymerization in the presence of the 
enzyme thrombin, has been used widely as a natural origin scaffold for wound healing and tissue 
engineering applications owing to its characteristic advantages including reduced inflammation, immune 
response, toxicity, and enhanced cell adhesion [64]. 
The major drawbacks associated with the use of protein based-polymers are their low mechanical 
stiffness and rapid degradation rate in vivo. In order to overcome these disadvantages, crosslinking 
techniques, including chemical and physical methods, have played a pivotal role for producing scaffolds 
with enhanced mechanical properties as well as means of making water insoluble scaffolds [53,54,65]. 
For example, Ulubayram et al. [66] optimized the effect of the type and the amount of cross-linker used 
on the thermal and mechanical properties, stability, and cytotoxicity of gelatin sponges. More recently, 
genipin and glyceraldehyde have been used as crosslinkers due to their low toxicity and reproducibility 
in the creation of gelatin-based scaffolds [67,68]. Furthermore, a range of various cross-linkers 
(transglutaminase, genipin, EDC/NHS, and UV light exposure) were tested in electrospun collagen 
nanofibers to avoid the poor water resistance of collagen [69]. Additionally, the combination with other 
artificial scaffolding materials could resolve this handicap as well. The addition of inorganic fillers in 
the polymeric structure is also another alternative to increase the required mechanical stability under 
operation rendering nanocomposites with superior properties. 
In regard to polysaccharide-based polymers, alkaline (chitin, chitosan), neutral (glucans, dextrans, 
cellulose), acidic (alginic acid, HA) or sulfonated polysaccharides (heparin, chondroitin, dermatan 
sulfate, keratan sulfate) are broadly used for the management of wounds. In that sense, films, gels, or 
sponges of chitosan have recently been investigated for their use in wound care, demonstrating 
antimicrobial and wound-healing effects [70]. In a parallel study, Tchemtchoua et al. [71] showed that 
the adhesion, growth, and differentiation of the three main skin cell types (keratinocytes, fibroblasts and 
endothelial cells) were enhanced when using chitosan nanofibrous scaffolds in comparison to other types 
of chitosan-based structures (films, sponges or gels). The natural polysaccharide alginate has also been 
proposed as suitable building materials in wound dressings. There are numerous studies concerning the 
application of different alginate-based formulations: chitosan-fibrin-sodium alginate composite for 
wound dressings [72], alginate nanofiber-based wound dressings [73], sodium alginate/poly(ethylene 
oxide) blend nanofibers [74], composite alginate, and gelatin-based bio-polymeric wafers for wound 
healing [75] and so on. 
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An important natural origin biopolymer of increasing interest is HA which assists in providing  
wound healing. Researchers have developed scaffolds based on HA for difficult-to-heal wounds,  
post-traumatic, and complicated surgical wounds [76–78]. Recently, gelatin-chondroitin-6-sulfate-HA [79], 
HA/Agarose [80] and photocrosslinked HA/fibronectin [81] based scaffolds have shown a great potential 
in wound healing scenarios. 
3.2.2. Synthetic Polymers 
The functions and properties (e.g., porosity, degradation time, and mechanical characteristics) of 
synthetic polymers can be tailored by modifications in the synthesis processes according to specific 
requirements and applications in order to overcome many of the presented shortcomings of natural origin 
polymers. So, the variation of the different parameters such as chemical composition, crystallinity, 
molecular weight, and copolymerization allow production of scaffolds with predictable and reproducible 
mechanical and chemical properties in large quantities. In addition, they are often cheaper than biological 
scaffolds and have a longer shelf life. 
FDA approved-aliphatic polyesters such as PLA, polyglycolic acid (PGA), PCL and their copolymers 
have being widely applied in skin tissue engineering and as wound dressings. In this regard,  
the development of several wound healing dressings such as curcumin-loaded PLA nanofibers [82], 
PGA/collagen composite nanofibrous scaffolds [83], nanofibrous scaffolds containing gum 
tragacanth/PCL [84] and poly(lactide-co-glycolic acid) (PLGA)/silk fibroin hybrid scaffolds [85] have 
demonstrated a great potential as wound healing materials. Sun et al. [86] showed that the use of 
ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound covers induces healing and 
inhibits hypertrophic scar formation. 
Other commonly synthetic polymers used as wound dressing include polyurethane (PU), polyvinyl 
alcohol (PVA), polyethyleneoxide (PEO) and polyethyleneglycol (PEG). For example, Yari et al. [87] 
analyzed the application of different cross-linked PU hydrogels with chemically anchored antibacterial 
groups as wound dressings. Besides, electrospun PU-dextran nanofiber mats containing ciprofloxacin 
HCl showed enhanced antibacterial activity [88]. Also, Dai et al. [89] demonstrated that electrospun 
emodin polyvinylpyrrolidone (PVP) blended nanofibrous membranes accelerated wound healing compared 
to standard treatments. An in vivo study carried out by Yun et al. [90] demonstrated that the use of a 
fibroblast-encapsulated PEG-b-poly(L-alanine) thermogel significantly improved the healing-process 
speed and also the dermal regeneration compared to control systems based on just cell-free  
PEG-b-poly(L-alanine) thermogel and PBS. In another study, it was demonstrated that PEG incorporation 
into ciprofloxacin hydrochloride loaded chitosan scaffolds was effective for quicker and regulated 
wound healing [91]. 
3.3. Fabrication (Electrospinning, Phase Separation, Auto-Assembly, etc.) 
A wide variety of techniques have been used to fabricate polymers into different types of nanostructured 
dressings in order to improve the wound healing processes and to ensure a good efficient drug loading. 
The fabrication of these dressings should be strictly controlled to obtain the appropriate features to 
perform a successful and rapid healing. In fact, porosity is a key factor in the promotion of new tissue 
formation because cell migration, proliferation, and differentiation are all affected by geometrical 
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constraints from the surrounding microenvironment, and it should be adapted for each application [92–95]. 
However, the required porosity depends on the proximity of capillary vessels to irrigate the wounded 
tissue. If the wound is close to a very well irrigated area the need of generating new angiogenesis, and 
the corresponding large pores, is reduced, but in less irrigated areas large pores are required in the 
scaffold to allow new capillary generation. Also the size of the remodeling zone is important to consider 
when the appropriated pore size scaffold is to be selected. Furthermore, parameters linked to porosity 
such as interconnectivity or changes mediated by degradation or remodeling should be carefully 
monitored [96,97]. 
In the last few years, one of the most extended methods for the fabrication of nanodressings is the 
electrohydrodynamic (EHD) technique or electrospinning. EHD techniques use electrostatic forces to 
produce from nano- to microstructures composed of continuous ultrafine fibers rendering multiple 
shapes due to the use of an electrically charged fluid stream which is collected in its corresponding 
counter-electrode the applied voltage being a crucial element in the formation of the fibers [98–100]. 
The features of the resulting structures regarding composition or morphology can be modified through 
the type of polymer or solvent used or even by modifying the injection speed, in order to fulfil the 
requirements for the envisaged applications which are diverse such as biomedical, pharmaceutical, or 
security and defense [98,101,102]. This simple technique has become very popular for the fabrication of 
these fibers because of its potential to easily scale up or the capability to spin very different types of 
polymers and also the simplicity and low-cost of the equipment required. The fiber is formed when after 
the application of a high electrical potential to a polymer droplet at the tip of an injection needle this is 
ejected when repulsion charges overpass surface tension. Finally, the solvent is evaporated in its way 
towards the grounded counter-electrode and fibers are collected (Figure 5) [102,103]. 
 
Figure 5. Electrospinning experimental set-up with its main components: syringe pumps,  
tip and collector. Coaxial injection capillaries can be used (image on the right) to fabricate 
nanofibrous core-shell structures. 
Electrospun fibers are widely used in dressings and in drug delivery applications due to their specific 
features such as high area to volume ratio, customized porosity, morphology, and functionalization which 
can provide them with hemostatic ability, protection against infections, adequate maintenance of moisture 
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or even mimicking the ECM [98,101,104–106]. Very different polymers have been used to produce 
these fibers from natural origin polymers (e.g., chitosan, collagen, HA), to synthetic polymers (e.g., 
PLLA, PCL) and copolymers (e.g., PLGA, poly(l-lactide-co-caprolactone)) in order to produce scaffolds, 
membranes or implants for tissue engineering and/or with drug delivery ability [98,100,103,107–113]. 
Specifically, electrospun PLLA/PEG materials exerted in vitro bactericidal and hemostatic effects [114] 
while electrospun collagen dressings have shown better in vivo healing ability than classic wound care 
systems [115]. Moreover, silk fibroin/PLGA electrospun nano-dressings displayed improved wound 
closure compared to just PLGA dressings and to control samples in an in vivo wound model of diabetic 
rats due to a demonstrated improved re-epithelialization process [85]. 
In addition, other techniques have been developed for the fabrication of nanofibers with biomedical 
purposes and high drug loading capacity though less extended than electrospinning. The phase separation 
technique involves the polymer dissolution, gelation, and solvent extraction followed by freeze drying 
or vacuum. Under specific conditions, a homogeneous polymer can be separated into two phases due to 
thermodynamic instability or even by mechanical shearing or emulsification of two or more phases,  
to finally obtain a solid polymer-rich phase. The structural characteristics of the final product can be 
modified changing the thermodynamics and kinetics of the specific reaction. In addition, this technique 
allows the loading of sensitive drugs without loss in their bioactivity [92]. Moreover, self-assembly is 
another technique to produce nanofibers which results in the formation of a nanofibrous mesh through 
the organization of preexisting components [116]. Fiber mesh and fiber bonding are other methodologies 
that imply the deposition of a polymer over another polymer followed by an evaporation stage, and the 
joining of nanofibers at their cross-linking points in order to produce nanofibrous meshes [92,117].  
In general, those techniques allow an easy, not expensive and vast production of nanofibers with high 
surface area, though the resulting structures, in general, do not show the required mechanical stability 
making control of the porosity difficult in the case of using phase separation, fiber mesh, and fiber 
bonding techniques; the resulting shapes are not as uniform as in self-assembly techniques, and the 
loading efficiency is low when using self-assembly or fiber mesh techniques [99,116,117]. 
3.4. Dressings for Controlled Drug Delivery to the Wound 
Drug delivery systems are biocompatible particles, hydrogels, dressings, or three-dimensional (3D) 
devices that are able to provide sustained doses of a therapeutic moiety in our body accomplishing 
increased safety and efficiency due to the tight control of the site of release, dosage, and timing [118–120]. 
In the last years, a great number of nanostructured materials have been developed for drug delivery 
because of the increased drug-dissolution rate of these structures through the superior surface area per 
volume ratio [103]. 
Bioactive wound dressings in different forms (e.g., hydrogels, films, electrospun fibers) have been 
developed in recent years to improve the protection against bacterial infections [121]. These dressings 
should fulfill some requirements to develop their functions properly such as maintain moisture, favor 
hemostasis and cell proliferation, and allow functionalization and good flexibility [103]. As mentioned 
above, electrospun fibers are being widely used to fabricate nanostructured dressings with drug delivery 
ability. Furthermore, biomacromolecules as well as hydrophilic and hydrophobic drugs can be directly 
encapsulated into electrospun fibers making their use as drug release systems easy. These features 
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together with their high surface area and 3D porous structure confer them with a high efficiency for drug 
delivery [101,102,122,123]. In addition, the local delivery provided by these types of fibers offer the 
possibility to reduce the minimum required drug dosage which implies less side effects [103]. 
The methodology to load a nanofiber with a specific drug should be highly specialized because drugs 
show different chemical characteristics and every disease needs the most suitable delivery system [103]. 
There are a wide number of techniques to achieve this goal by combining the most used. This 
methodology involves one-step electrospinning due to the dissolution or dispersion of the drug in an 
appropriated solution of the polymer [119,124]. Although it is a very simple technique, it is of great 
importance to know the drug distribution into the fibers and their possible interactions and drug kinetics 
to achieve the required release. Some researchers have improved this loading technique by adding 
hydrophilic polymers or amphiphilic copolymers or even by increasing the hydrophilicity of the fibers 
to obtain a higher loading efficiency and improved sustained release [121,125–127]. There are also other 
techniques used for drug loading in electrospun nanofibers in order to improve sustained delivery and 
maintain drug chemical properties, such as the modification of the fiber surface by bounding or 
conjugation of the drug to the surface of the nanofibers which is useful for achieving a slow release of 
therapeutic biomolecules (e.g., growth factors, genetic material) [102,103,128]. A modification of the 
electrospinning process called coaxial electrospinning in which the drug is placed in the inner jet and the 
polymer is in the outer tubing is also used to achieve a long term drug release [129]. The emulsion of 
the drug within the dissolved polymer or the sequential electrospinning to load more than one drug for 
combination therapies are also strategies widely used [101,103]. 
In this sense, several authors have shown very different studies in which electrospinning is the 
technique of choice to fabricate drug delivery nanodressings. A wide variety of materials have been used 
such as PLGA, poly(vinyl acetate), or cellulose, together with different drugs such as antibiotics,  
anti-inflammatory, antioxidants and/or natural origin compounds, demonstrating a higher efficiency than 
drug-loaded films [121,130–132]. For instance, Choi et al. [102] have shown in a mice diabetic ulcer 
model that the use of PCL or PCL-PEG nanodressings loaded with epidermal growth factors (EGF) 
clearly outperformed the healing of wounds compared to the nanodressings alone or with the  
non-treated wounds. In addition, these authors confirmed the beneficial effects of this type of dressings 
in keratinocyte expression in an in vitro model. Other researchers [133] have developed an in vivo wound 
healing model in diabetic rats highlighting the rapid and efficient restoration of the skin structure and 
function when wounds were treated with coaxially fabricated electrospun fibers loaded with basic 
fibroblast growth factor (bFGF). The gradual release of the growth factor resulted in higher capillarization, 
collagen deposition, and ECM remodeling in a similar fashion compared to normal skin. Furthermore, 
they also showed in vitro enhanced cell adhesion, proliferation and secretion of ECM in a mouse embryo 
fibroblast model. 
Other researchers have focused their research on modifying textile dressings with magnetic 
nanostructures to prevent the evaporation of the natural origin compounds limonene and eugenol or other 
essential oils embedded in the dressings to achieve sustained bactericidal ability against different strains 
of bacteria [134,135]. 
There are also studies regarding the production of drug-eluting porous structures for wound dressing 
through the methodology of freeze drying of inverted emulsions [92,99]. In this regard, Elsner et al. [92] 
stated that drug loading can be performed with this technique at any stage of the fabrication without any 
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drug loss or modification due to temperature or chemical interactions. In this case, drug release was 
modulated through the degree of porosity which in turn may be modified by controlling the 
organic:aqueous ratio or drug content. This study showed the high efficiency of these nanodressings 
loaded with the antibiotics gentamicin and ceftazidime against Staphylococcus aureus, Staphylococcus 
albus and Pseudomonas aeruginosa, both in vitro and in vivo, to improve wound healing processes. 
4. Essential Oils, Honey, Aloe Vera, Cationic Peptides and other Natural Origin Antimicrobial, 
Anti-Inflammatory and Regenerative Compounds 
This section encompasses the literature published in the last years describing the application of 
naturally occurring antimicrobials, anti-inflammatory and regenerative molecules in the acceleration of 
the wound-healing process. A wealth of in vitro and in vivo studies with animal models demonstrates 
the antimicrobial, anti-inflammatory, and regenerative properties of essential or edible oils, honey, aloe 
vera, plant extracts, cationic peptides, etc.; however in the sake of concision we shall only review those 
results which involve clinical trials. Results from enteral administration of these natural origin 
components have also been excluded in this review. 
4.1. Antimicrobials 
Everything has antimicrobial properties depending on its dose. “The dose makes the poison” is the 
basic principle of toxicology (credited to Paracelsus). The idea behind this section is to be thought-provoking, 
trying to compare the potential benefits from natural-origin materials topically applied against 
pathogenic microorganisms colonizing wounds compared to the conventional synthetic topical 
antiseptics (iodine, silver, chlorhexidine, polyhexamethylbiguanide, etc.) or with the systemic 
application of antibiotics and also always keeping in mind the required dose needed to reach the same 
antimicrobial level. It is important to mention that to prevent wound infection the use of topical 
antibiotics is not recommended due to the risk of sensitization and development of resistance.  
Natural origin materials have been used in wound care with positive results. 
Natural origin materials can be antimicrobials or can boost the defenses of the infected host. As we 
mentioned before, when the antimicrobial is applied on the wound or on intact skin they are called 
antiseptics [136]. Obviously the material of choice to accelerate the physiological wound healing process 
must have antimicrobial action on bacteria, yeast, fungi, virus, and spores but should be non-cytotoxic 
on human cells without the development of any antimicrobial resistance. 
Honey has been used as antimicrobial for centuries. The composition of the honey depends on the 
floral source that the honeybees use and also on the environmental conditions [137]. Its antimicrobial 
action is attributed to its acidic pH, high osmolarity, and to the presence of hydrogen peroxide (reactive 
oxygen species (ROS) generation), antioxidants, lysozyme, polyphenols, phenolic acids, flavonoids, 
methylglyoxal, and bee peptides [137]. A prospective, multicentre, open label randomized controlled 
trial with 808 patients with venous leg ulcers having ≥50% wound area covered in slough not taking 
antibiotics or immunosuppressant therapy were recruited to compare the efficacy of manuka honey 
versus current hydrogel therapy [138]. The results showed that patients treated with the manuka honey 
had increased incidence of healing, effective desloughing and a lower incidence of infection than the 
controls. However, Jull et al. [139] carried out a community-based open-label randomized trial on 
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patients with venous ulcers using either calcium alginate dressings impregnated with manuka honey (187 
patients) or usual care (181 patients) and showed that honey-impregnated dressings did not significantly 
improve venous ulcer healing at 12 weeks compared with the usual care. Another prospective open label 
multicenter study with 108 patients with sloughy venous leg ulcers treated with manuka honey or 
hydrogel showed a benefit of one versus the other depending on the bacteria present [140]. A randomized 
study with 69 patients using honey-coated bandages compared with silver-coated bandages on the 
treatment of malignant wound showed no differences between both groups [141]. In a prospective 
randomized study (45 subjects) to compare the effectiveness of honey dressings vs. povidone iodine 
dressing in chronic wound healing, honey dressings showed a significant decrease in the wound surface 
area, pain score and increase in comfort score compared to the iodine-based ones [142]. Shorter times of 
healing and a rapid disinfection of neuropathic diabetic foot ulcers were observed when using  
manuka honey-impregnated dressings compared to conventional dressings in a randomized clinical trial 
(63 patients) [143]. Literature reports varied results for honey depending on the infected wound [144] 
and also it has been demonstrated that honey may even have a detrimental effect on diabetic ulcers [145]. 
These contradictory results indicate that more information is needed and multi-center clinical trials and 
with a larger number of patients are required to show a clinical benefit for honey to reduce the incidence 
of wound infection [146]. 
Essential oils are composed of 20–80 constituents existing at significantly low concentrations in 
plants which chemical composition depends on climatic, seasonal, geographic conditions and distillation 
technique [147]. Their antimicrobial action is attributed to some of their varied components including 
terpenes, low molecular weight aliphatic hydrocarbons, acids, alcohols, aldehydes, acyclic esters, etc. 
Different edible oils extracted from fruits have antimicrobial action which is attributed to their acidic pH 
and to the presence of simple phenols and oxygenated compounds. The great advantage is that essential 
oils show little impact on the development of antimicrobial resistance and susceptibility compared to 
other biocidal components [148,149]. 
Darmstadt et al. [150] demonstrated that premature babies (159) who received a daily massage with 
sunflower-seed oil were 41% less likely to develop nosocomial infections than controls (without any 
treatment) and Aquaphor (petrolatum, mineral oil, mineral wax, lanolin alcohol; 157 babies) did not 
significantly reduce the risk of infection. 
A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for 
the clearance of methicillin-resistant S. aureus (MRSA) colonization was carried out by Dryden et al. [151]. 
In this study 114 patients received standard treatment and a 49% of them were cleared of MRSA carriage. 
110 patients received tea-tree oil regimen and only a 41% of them were cleared. The authors concluded 
that there was no significant difference between treatment regimens and, from the same study they also 
concluded that tea-tree treatment was more effective than chlorhexidine or silver sulfadiazine at clearing 
superficial skin sites and skin lesions. A recent prospective, open-label, randomized, controlled trial with 
445 patients was carried out to determine whether the daily use of 5% tea-tree oil body wash compared 
with standard care had a lower incidence of MRSA colonization [152]. The results showed that a 10% 
of the patients developed new MRSA colonization and therefore, compared with standard care, the daily 
use of 5% tea-tree oil body wash cannot be recommended as an effective means of reducing  
MRSA colonization. 
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Essential coriander oil was very efficient as an antiseptic for the prevention and treatment of skin 
infections with Gram-positive bacteria (Streptococcus pyogenes, S. aureus and MRSA) [153]. In addition, 
no skin irritation could be observed by sensitive photometric assessment in any of the 40 volunteers 
using patches impregnated with this essential oil. 
Lavender oil was used in the treatment of recurrent aphthous ulceration by means of randomized 
double-blind, placebo-controlled study performed in animal models and also in 115 subjects [154].  
A significant ulcer-size reduction, increased rate of mucosal repair, and healing within three days of 
treatment were observed in the animals treated with lavender oil compared to baseline and placebo 
groups. Lavender oil showed a broad antibacterial activity against different tested strains and the patients 
treated with lavender oil showed a significant reduction in inflammation level, ulcer size, healing time, 
and pain relief. As in the case of honey-based products, the literature compiles contradictory or at least 
insufficient results to make a scientific conclusion about the demonstrated benefit of those essential oils. 
Antimicrobial peptides are an evolutionarily conserved component of the innate immune response 
found among all classes of life ranging from prokaryotes to humans which show antimicrobial activities 
against Gram-positive and Gram-negative bacteria [155]. They act with multiple roles as mediators of 
inflammation with the effects on epithelial and inflammatory cells, influencing cell proliferation, wound 
healing, cytokine/chemokine production and chemotaxis [156]. They also do not seem to propagate the 
development of antibiotic-resistant micro-organisms [157]. Lipsky et al. [158] described the results of 
two consecutive, double-blind, randomized controlled trials on diabetic patients with a mildly infected 
diabetic foot ulcers to receive an active topical antimicrobial peptide, pexiganan acetate cream, or an 
active oral antibiotic (ofloxacin), plus a respective inactive placebo. The results with a total of 835 
subjects showed equivalent results (within the 95% confidence interval) for topical pexiganan and oral 
ofloxacin in clinical improvement rates, overall microbiological eradication rates, and wound healing 
rates. A significant reduction of infectious complication after major liver surgery was also observed in a 
clinical trial with patients using bactericidal/permeability-increasing protein (rBPI (21)) [159]. 
Despite some of those good results, the main drawback is their high cost and also that it is difficult  
to maintain a constant optimal therapeutic level due to the short half-life of recombinant proteins  
in vivo [160]. 
Several pathogenic bacteria are developing antibiotic resistance and therefore, initially the study of 
the potential applicability of those natural occurring antimicrobial agents is justified [161,162]. 
However, as in the case of nanosilver, more studies are need to assess their potential role in antimicrobial 
resistance [163]. 
4.2. Anti-Inflammatory 
Tea-tree oil thanks to its main component, terpinen-4-ol, can reduce histamine-induced skin 
inflammation as demonstrated in a study with 27 volunteers [164]. Javed et al. [165] reviewed the role 
of dentifrices with essential oil formulations in periodontal healing retrieved from 20 clinical trials from 
1968 to 2010 and concluded that dentifrices formulated with essential oils have beneficial effects on the 
clinical and microbiological parameters of periodontal inflammation. 
Oral lichen planus is a chronic inflammatory condition that affects mucous membranes of the mouth. 
A randomized, double-blind, clinical trial involving 40 patients comparing the benefits of using aloe 
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vera versus triamcinolone acetonide (a topical corticosteroid) demonstrated that aloe vera gel was more 
effective than the corticosteroid in the treatment of oral lichen planus [166]. 
Lalicevic and Djordjevic [167] compared in an open-label, single-blind, randomized clinical trial 
benzydamine hydrochloride (BNZD) and Salvia officinalis (SO) as adjuvants applied locally to a 
systemic nonsteroidal anti-inflammatory drug (ibuprofen for children and diclofenac in adults) in 
controlling pain after tonsillectomy, adenoidectomy, or both. In this study, they showed that the risk for 
severe pain after tonsillectomy, adenoidectomy, or both was reduced when BNZD was used as adjuvant 
therapy instead of SO. Also there was a lower infection risk when BNZD, rather than SO, was applied 
as adjuvant therapy. 
4.3. Regenerative 
Healing advances were observed in a clinical trial with 120 primiparous women, with singleton 
pregnancy, who were treated during episiotomy recovery either with lavender oil or with povidone-iodine 
(controls). The results concluded that there was no significant difference between those two groups in 
surgery-site complications. However, redness in lavender group was significantly less than in  
controls [168]. Another clinical trial with 89 women was carried out to analyze the recovery after 
episiotomy using lavender based-on olive oil and olive oil [169]. The results also suggested that lavender 
based-on olive oil and olive oil should be added to routine water sitz bath for post-episiotomy care.  
In another clinical trial involving 111 primiparous women, Eghdampour et al. [170] demonstrated that 
women treated either with aloe vera or with calendula ointment showed a faster episiotomy wound 
healing compared to the untreated group. 
A clinical study involving 30 patients treated with sesame oil or just with saline having fresh traumatic 
wounds showed that this oil was effective by reducing pain, minimizing wound surface, reducing the 
discharge and promoting the epithelialization compared to the controls [171]. 
Aloe vera gel has been traditionally used to treat burn wounds and several studies concluded that 
cumulative evidence tends to support that aloe vera might be an effective interventions used in burn 
wound healing for first to second degree burns but the same study states that more studies are needed to 
corroborate it [172]. A systematic review of the literature including clinical trials concluded that 
controlled clinical trials in humans demonstrated no benefit when aloe vera was incorporated into topical 
therapy [173]. 
A prospective randomized double-blind clinical trial was conducted with 90 women who had 
undergone cesarean operation applying aloe vera or just a simple dressing. A significant difference was 
observed between the two groups with respect to the wound healing score 24 h after the operation; 
however after eight days, the difference in the wound healing score was not significant [174]. 
A prospective clinical trial was conducted with 60 patients to evaluate the effects of a topical cream 
containing 0.5% aloe vera juice powder in the treatment of chronic anal fissures by Rahmani et al. [175]. 
The study concluded that there were statistically significant differences in chronic anal fissure pain, 
hemorrhaging upon defection and wound healing before and at the end of the first week of treatment 
with the gel in comparison with the untreated group (placebo). A comparative study stablished between 
second degree burn patients (50) treated with aloe vera gel compared with those treated with 1% silver 
sulphadiazine cream showed that faster wound healing and less pain were reported for the group treated 
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with the aloe [176]. Once again we found controversial results or incomparable results because the effect 
of any antiseptic depends on the wound type, chronicity, the moment to apply the therapeutic compound, 
the condition of the patients, origin, age, combinatory effects, contact time, the antiseptic of choice for 
a particular (e.g., bacterial strain) infection, etc. 
Propolis, a resinous mixture that honey bees collect from tree buds, sap flows, or other botanical 
sources, was also used in a clinical trial to study its influence in the treatment of recurrent aphthous 
stomatitis, a common, painful, and ulcerative disorder of the oral cavity [177]. The results obtained 
indicated that patients in the propolis group self-reported a significant improvement in their quality of 
life and a statistically significant reduction of outbreaks compared to the untreated controls. 
A randomized clinical trial of 37 patients with neuropathic diabetic foot ulcers was set to analyze the 
benefits of extract of kiwifruit compared to a standard dressing treatment [178]. The group treated with 
the kiwifruit experienced a larger reduction in the size of the ulcer than the untreated one at the same time. 
The amount of collagen, angiogenesis, vascularization and granulation tissues were significantly higher 
in the experimental groups than in the controls. Wound healing kinetics were also evaluated on 34 patients 
with chronic venous leg ulcers treated either with the plant species Ageratina pichinchensis or with 7% 
propylene glycol alginate [179]. The results showed that the plant extract produced a 100% therapeutic 
effectiveness, while the control treatment achieved this condition in 81.8% of the control group patients. 
Ulcer size reduction was significantly higher in the group of patients administered with the extract. 
Banana leaf, tree bark, cocoa, turmeric, β-glucans, etc. have also demonstrated their antioxidant,  
anti-inflammatory, antimicrobial, and angiogenic properties in in vitro studies and, for some of them,  
in clinical trials [180]. 
There is an endless list of natural origin products which have been used since antiquity to heal 
wounds, but still scientific evidence of those properties is still to be demonstrated using double-blinded 
multi-center randomized placebo-controlled trials to reach a sufficient level of evidence. 
4.4. Dose Analysis 
To compare the doses needed to obtain the same output in the prevention of infection during wound 
healing when using natural origin components or synthetic ones we compared the minimal inhibitory 
and minimal bactericidal concentrations (mic and mbc, respectively) published for just honey in the sake 
of concision. In this regard Tan et al. [181] calculated the mics for two different honeys against nine 
different bacteria (S. pyogenes, coagulase-negative Staphylococci, MRSA, Streptococcus agalactiae,  
S. aureus ATCC 33591, Proteus mirabilis, Shigella flexneri, Escherichia coli and Enterobacter cloacae) 
and the values ranged from 8.75% (w/v) to 25% for tualang honey, while those for manuka honey ranged 
between 8.75% and 20% (w/v). The mics and mbcs reported by Henriques et al. [182] when challenging 
S. aureus NCTC to manuka honey were 2.9% (w/v) and 4.5% (w/v) as mean mic and mbc values, 
respectively. Against P. aeruginosa ATCC 27,853 the doses required of manuka honey were 9.5% (w/v) 
and 12% (w/v), mic and mbc respectively. 
Mic and mbc doses of 20% (w/v) and 40% (w/v), respectively were required when using manuka 
honey against biofilm forming strains of S. pyogenes MGAS6180 [183]. Against oral bacteria 
(Streptococcus mutans adhered on a glass substrate), Badet and Quero [184] reported a total inhibition 
of multi-species biofilm at the concentration of 200 μg/mL using manuka honey and a total biofilm 
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inhibition was reached at a concentration of 500 μg/mL. Propolis was much more effective against S. 
aureus and Escherichia coli compared with honey as reported by Rahman et al. [185]. These authors 
estimated that propolis at concentrations of 2.74 to 3.5 and 3.5 mg/mL is effective to inhibit S. aureus 
and E. coli, respectively. On the contrary, honey was effective to inhibit S. aureus at the concentration 
of 375 mg/mL but failed to inhibit E. coli growth at same concentration. 
Different Malaysian honeys were evaluated against S. aureus, Bacillus cereus, E. coli, and  
P. aeruginosa and compared using equivalent phenol concentrations (EPC) [186]. The results showed 
that gelam honey possessed lowest mic value against S. aureus with a 5% (w/v) mic and mbc of 6.25% 
(w/v). The highest mic values were shown by pineapple honey against E. coli and P. aeruginosa as well 
as acacia honey against E. coli with a 25% (w/v) mic and a 50% (w/v) mbc values. Agar inhibition assay 
showed kelulut honey to possess highest total antibacterial activity against S. aureus with 26.49 EPC 
and non-peroxide activity of 25.74 EPC. Lowest antibacterial activity was observed in acacia honey 
against E. coli with total activity of 7.85 EPC and non-peroxide activity of 7.59 EPC. 
The antimicrobial efficacy of conventional antiseptics has been reported against S. aureus (including 
MRSA), Enterococcus faecalis (including vancomycinresistant Enterococcus), Streptococcus pneumoniae, 
E. coli, P. aeruginosa, Clostridium perfringens, Haemophilus influenzae and Candida albicans using 
PVP-iodine, triclosan, chlorhexidine, octenidine and polyhexanide as conventional antiseptics used in 
wound treatment [187]. The results showed that for chlorhexidine, octenidine and polyhexanide, mic48 
and mbc24 ranged from 16 to 32 mg/L. Maximum values for triclosan ranged from 256 to 512 mg/L, 
with an efficacy gap against P. aeruginosa, while the maximum values of PVP-iodine were 1024 mg/L, 
with a gap against S. pneumoniae. Comparing the minimal effective concentrations, octenidine was the 
most effective. After 1 min, only octenidine and PVP-iodine fulfilled the requirements for antiseptics. 
We can conclude that, according to those reported data, honey shows mic and mbc values in the same 
order of magnitude than conventional antiseptics and potentially applicable after validation in clinical 
settings. As an example, commercially available dressings based on chemically treated honey are 
nowadays available in Europe [188]. 
5. Combination of Nanostructured Dressings with Essential Oils 
As we mentioned in the previous section, it was already demonstrated that some naturally occurring 
molecules have antimicrobial [137,151,153], anti-inflammatory [164,166,167] and regenerative 
properties [172–178]. From a fabrication point of view, besides the advantages already mentioned of 
these natural origin materials over antibiotics, their hydrophobicity allows an efficient combination with 
polymeric matrices often used as wound dressings [189]. Several strategies were used to load essential 
oils in dressings; the first is the modification of commercial wound dressing by immersion in active 
principle solutions; the second is the preparation of polymeric films containing those essential oils and 
the third one is their encapsulation into the polymeric fibers.  
5.1. Modification of Commercially Available Wound Dressings 
As previously mentioned (Section 4.1), honey impregnated dressings were tested by different 
researchers with controversial results [139,141–143,146], suggesting that the benefits of adding honey 
to dressings to reduce the rates of wound infection deserves further research. 
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Edwards-Jones et al. [38] impregnated aliquots of tea tree (Melaleuca alternifolia), patchouli 
(Pogostemon cablin), lavender (Lavendula officinalis), geranium and commercial grapefruit extract 
(Citridal™) and their combinations on the central area of either a gauze or Gamgee® dressing. The 
activity of individual oils and combinations against S. aureus were studied in an in vitro dressing model. 
Results showed that Geranium and Citricidal™ was the most effective combination against MRSA 
strains in the vapor phase, but this combination was not as effective against Oxford Staphylococcus. 
More recently this in vitro study was moved towards clinical trials by Chin et al. [190]. These researchers 
used the same dressing model with patients who had wounds infected with S. aureus. They found that 
all participants treated with tea tree oil, except one, showed accelerated healing times. The use of this 
essential oil in wound dressings appears to be a safe complementary treatment of abscessed wounds. 
These results suggest that there is, in this case, a correlation between in vitro models and in vivo 
scenarios. Since this was a small study (only 10 volunteers) a larger study controlling as many variables 
as possible is needed as we mentioned in our previous section. 
The effect of Valencian orange oil against MRSA was also evaluated in a dressing model [191].  
The orange oil was spotted into cotton dressing pads placed on Petri dishes seeded with MRSA and 
wrapped with a bandage as shown in Figure 6. The growth of MRSA strains was inhibited by the vapor 
released from the dressing pad and exhibited clear inhibition zones on agar plates (Figure 6f–h) 
demonstrating that essential oils can be applied as natural origin anti-MRSA agents on the outer layer of 
a dressing. 
 
Figure 6. Dressing model using an agar plate. (a) arrows indicate the cold pressed Valencia 
orange oil spots on gauze dressing pad; (b) complete setup of dressing model with gauze 
dressing pad wrapped with bandage. Untreated control plates of bacterial strains S. aureus: 
(c) COL; (d) Mu50; and (e). Inhibition of S. aureus: (f) COL; (g) Mu50; and (h) caused by 
the cold pressed Valencia orange oil [191]. (Copyright BioMed Central 2012). 
Budzynska et al. [192] modified the commercial dressing Sorbact® by its immersion in an essential 
oil solution (Melissa citrate indica, Pelargonium graveolens, Cymbopogon nardus and Eugenia 
caryophyllata) to evaluate its antimicrobial action. The dressing containing essential oils could keep 
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absorbed bacteria/fungi inside and efficiently limit their growth. As we mentioned before, in order to 
avoid the problem of the high volatility of the essential oils and to improve their stability they were 
combined with magnetite nanoparticles (MNP) [135]. The MNP functionalized with the essential oil of 
Anethum graveolens (AG) and SO were added to sterile rayon/polyester based wound dressing by 
immersion in a chloroform suspension and posterior drying. Both essential oils showed a significant 
decrease in C. albicans viable cell counts; they preferentially inhibited the early stages of biofilm 
formation (after 24 h) but also reduced the formation and development of mature biofilms. Due to the 
different release profiles of the two oils, the inhibitory effect of AG reached a maximum at 48 h while 
SO reached the maximum at 72 h. Both essential oils increased the resistance of the dressing to fungal 
colonization. The same group also proved that Satureja hortensis essential oil attached to MNP added 
to commercial dressing exhibited antimicrobial properties being more resistant to C. albicans fungal 
adherence and biofilm development [193]. Holban et al. [194] also had used magnetite nanoparticles to 
stabilize carvone, the major active compound found in Anethum graveolens essential oil. Textile wound 
dressings containing these functionalized nanoparticles significantly reduced microbial adherence and 
fungal mature Candida tropicalis biofilm formation for 72 h. 
Other strategies should be implemented to reduce the high volatility of the essential oils which  
might lead to a burst release of the antibacterial compounds. A sustained long-term release is necessary 
in order to employ these dressings during the healing process of different wounds and/or at different 
wound stages. 
5.2. Polymer Films and Foams Containing Essential Oils 
Another way to fix those essential oils to the dressings is their incorporation into polymeric films to 
prevent their evaporation and burst release. The load of the bioactive species into the films could be 
performed in a very simple way by casting a solution of the polymer and the essential oil choosing the 
appropriated surface chemistry to adsorb or chemisorb the essential oil into the polymer. 
In this regard, thymol, a monoterpene of the essential oil from Lippia gracilis, was mixed in a collagen 
solution in order to obtain a collagen-based containing thymol film. The dispersion was then casted and 
allowed to dry [195]. Sterilized pieces of the obtained films were tested to evaluate their anti-inflammatory 
effects on rats and mice. The results revealed that thymol significantly ameliorated inflammatory 
responses and possessed wound healing potential. The films promoted wound contraction in only 7 to 
14 days. Moreover, thymol induced a more regular and dense collagen arrangement of the granulation 
tissue fibrils/fibres, suggesting that this molecule might also favor fibroblastic proliferation and  
collagen deposition. 
Thymol was also used to load gelatin films to examine their antioxidant and antimicrobial  
action [196]. In this case, the films were also prepared by casting gelatin, glycerol as plasticizer, 
glutaraldehyde as cross-linker and thymol. The resulting gelatin films showed good mechanical 
properties and the presence of this natural origin monoterpene also increased the solubility and reduced 
the swelling and water uptake. Gelatin films incorporated with thymol exhibited excellent antioxidant 
and antibacterial properties. However, the same authors pointed out that further in vivo research is needed. 
Chitosan is another polymeric matrix that has been used to host thyme oil. Altiok et al. [197] 
incorporated this essential oil into chitosan films by solvent casting. Chitosan was selected because of 
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its demonstrated nontoxicity, biodegradability, biofunctionality, biocompatibility and depending on its 
deacetylation degree and molecular weight, antimicrobial characteristic. Tensile strength and Young’s 
modulus were reduced by the incorporation of thyme oil because of the resulting porous structure after 
the addition of the oil. But this porosity also leads to higher values of water vapor permeability and 
higher oxygen diffusion, properties that, as we mentioned before, are desirable during the wound healing 
process to maintain the moisture balance. The antimicrobial activity of the films was evaluated against 
four different pathogens: E. coli, Klebsiella pneumoniae, P. aeruginosa and S. aureus. The highest 
antimicrobial effect was achieved against K. pneumoniae at 1.2% (v/v) of thyme oil being the minimum 
concentration which prevents the growth of all selected microorganisms. Those films also showed 
antioxidant activity, although further studies are necessary to determine the cytotoxicity of the prepared 
films in order to confirm the potential of thymol loaded chitosan films as wound dressing materials. 
Sodium alginate (NaAlg) is also preferred as a construction material for wound dressing applications 
since it has shown wound healing properties [198]. Liakos et al. [199] blended Elicriso italic, chamomile 
blue, cinnamon, lavender, tea tree, peppermint, eucalyptus globulus juvenile, lemongrass, and lemon 
essential oils with NaAlg solutions containing also glycerol as plasticizer. Igepal, as surfactant, was also 
added to the solution in order to control and minimize the size of the highly hydrophobic essential oil. 
The resulting solutions were then cast onto glass slides to obtain the films. The antibacterial and 
antifungal activities of the prepared films were tested against E. coli and C. albicans. Cinnamon,  
tea tree, peppermint and lemongrass loaded films were able to inhibit the growth of C. albicans at all the 
concentrations studied (15%, 50% and 66%) and they were able to inhibit E. coli at the intermediate and 
highest concentrations. Lavender was able to inhibit both microorganisms at the intermediate and highest 
concentrations. Eucalyptus and lemon were incapable to stop the E. coli growth but lemon successfully 
inhibited the growth of C. albicans in all concentrations and eucalyptus in the intermediate and highest 
ones. Elicriso oil was found to be effective against fungal colonization only at the highest used 
concentration and chamomile blue was the only essential oil which was found to be ineffective against 
both E. coli and C. albicans in all the studied concentrations. 
Another polymer used to prepare films loaded with essential oil is PVA because this polymer shows 
excellent mechanical and barrier properties. Kavossi et al. [200] prepared PVA films incorporated with 
Zataria multiflora essential oil by casting. The resulting films showed antifungal activity against 
Paecilomyces variotii, Trichoderma harizanum, Aspergillus oryzae, and Aspergillus niger. The authors 
claimed that this oil is a good source of phenolic monoterpenes (thymol and carvacrol) that easily 
interfere with the phospholipids present in the cell membranes. 
The solution casting method to obtain polymeric films loaded with essential oils even if it is a 
relatively simple method can have some drawbacks including the use of organic solvents, low incorporation 
yields and resulting in heterogeneous dispersions. Dias et al. [201] proposed supercritical solvent 
impregnation to overcome most of these limitations. The use of supercritical carbon dioxide avoids the 
use of organic solvents and allows the possibility to work at low temperatures and with most of the 
polymeric matrices usually intended for wound dressings. Using this method they added quercetin and 
thymol as bioactive compounds to natural-based polymeric matrices: N-carboxybutylchitosan (CBC) 
and agarose (AGA). CBC films and foams of both polymers were prepared by solvent casting and freeze 
drying, respectively. These foams and films were loaded with a high pressure mixture of bioactive 
compound supercritical CO2 and a co-solvent (ethanol). The in vitro study revealed that all quercetin/thymol 
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was released during a 9 h period. As expected, the higher porosities of foam-like structures permitted 
the loading of higher amounts of the essential oils and an increased available surface area. The systems 
presented adequate water vapor adsorption and transmission rates that were in the range required during 
wound healing. 
5.3. Fiber-Based Mats 
Wound dressings composed of polymer woven or non-woven microfibers or nanofibers (natural 
origin and synthetic) have received significant interest because of their outstanding characteristics [202,203] 
but just a few of the reported materials incorporate essential oils in their formulation. 
Alginate fibers produced by wet spinning were loaded with eucalyptus essential oil by doping the 
spinning solution of alginic acid with the bioactive compound [204]. Divalent cations (Ca2+) were used 
in the coagulation bath to cross link the alginic acid polymer chains by the formation of junction zones 
(egg-box model). The antibacterial activity of the resulting fibers was confirmed against S. aureus. 
PCL and PLA nanofibrous mats loaded with thymol were prepared by Karami et al. [205] by 
dissolving the polymers in a mixture of chloroform and dimethylformamide together with thymol.  
The authors found that thymol acts as plasticized and rearranged the polymer chain layer leading to a 
decrease in the viscosity of the polymer solution and, as a consequence, the average nanofiber diameter 
was reduced. Due to the limited solubility of thymol in the electrospun polymer solutions only 1.24% 
v/v of herbal drug could be loaded in the fibers. A bimodal release profile was observed: in the first  
12 h there was a burst release, following by a gradual drug release observed up to 48 h. The antibacterial 
evaluation of the hybrid mat carried out via the disc diffusion method resulted in the formation of 
inhibition zones of 10.4 and 7.8 mm against S. aureus and E. coli, respectively. The performance of the 
PCL/PLA mat containing thymol in an in vivo rat wound healing model showed a faster healing than 
when using a Comfeel® Plus commercial dressing. This improvement in the healing process was 
attributed to the water vapor permeability of the electrospun mats (3–4 mg/cm2h−1) compared to the not 
permeable commercial material (Figure 7). 
 
Figure 7. Cont. 
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Figure 7. (a) Photographs obtained from wounds covered with (A) gauze, (B) Comfeel® 
Plus, and (C) electrospun PCL/PLA (50/50) nanofibrous mats containing thymol at different 
times: 1, 3, 7, 10, and 14 days. (b) Degree of closure (%) for wounds treated with gauze, 
Comfeel Plus, and electrospun PCL/PLA (50/50) nanofibrous mats containing thymol after 
days of post-treatment [205]. (Copyright Jonn Wiley & Sons 2013) 
Cinnamon, lemongrass, and peppermint essential oils were encapsulated in electrospun cellulose-based 
nanofibers [189]. Solutions of the cellulose acetate and the essential oils in acetone were electrospun to 
obtain the loaded fibers. Antimicrobial assays using E. coli demonstrated that fibers encapsulating  
6.2 and 25 wt. % of essential oils were able to effectively stop upon contact the proliferation of E. coli. 
The comparison of the bactericidal activity of the resulting fiber mats versus planar films showed that 
the fibrous network strongly enhances the antibacterial effect against E. coli (~1.5 µm in diameter) [200]. 
However, against C. albicans (~4 µm in diameter), even with a 40 w/w % of essential oils in the cellulose 
acetate solution was not capable to successfully inhibit their growth. According to the authors, E. coli 
was able to penetrate inside the fiber matrix (empty space around 2–10 µm) and get in direct contact 
with the antibacterial material, while C. albicans cells did not penetrate inside the mesh of the mat and 
therefore they were only in contact with the outermost layers. The biocompatibility of the mats was 
evaluated using two in vitro cell models: immortalized fibroblasts and normal human keratinocytes.  
The unloaded fibers mats exhibited high cell compatibility and no cytotoxicity at the doses tested and 
the morphological analysis revealed that the cells can attach and spread on the fibers’ surface. But a 
reduction in the cell viability was observed for essential oil loaded fibers due to the anti-proliferative 
effect of the compounds against eukaryotic cells [206,207]. 
6. Conclusions 
Wounds are undoubtedly a severe problem for patients’ health and quality of life as well as for the 
health care system. The chronicity of a wound is usually derived of previous pathologies which hamper 
wound healing. The basic concept of tissue, infection/inflammation, moisture, and edge of wound 
remains as the best care in order to speed up the natural healing process. Nowadays, wound care 
practitioners are aware of the importance of both wound examination and assessment of the general 
health status of the patient to achieve successful wound healing. 
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Topical wound dressings play an important role in the wound management and their therapeutic 
availability has increased remarkably in the past years. However, in spite of wide variety of existing 
dressings (passive, interactive and bioactive) on the market, there is not any wound dressing that fulfills 
all the requirements to be applied in the different stages of wound healing. Therefore, the search for an 
ideal dressing continues to be a challenge in the tissue engineering field. Novel strategies in wound repair 
are currently centered on the development of 3D scaffolds with structural and biochemical similarity to 
the natural ECM. Nanotechnological advancements have allowed creating materials and devices that are 
overcoming some of the limitations of the current dressings. Thus, nanofibrous scaffolds made of natural 
origin and/or synthetic polymers hold great potential for wound dressings because of their unique 
properties such as high surface area to volume ratio, adequate porosity, and biocompatibility. 
Electrospinning has become the most used technique for the fabrication of nanodressings due to its 
simplicity and versatility. The loading of different types of therapeutic compounds such as drugs, 
biomacromolecules or other natural origin compounds with antimicrobial, anti-inflammatory or 
regenerative properties in those nanofibers is attracting much attention because of the possibility to 
improve the current bioactive dressings with the perspective of achieving better therapeutic alternatives 
to non-healing wounds, which also might fulfil the reduction of adverse side effects and the protection 
against wound infection. 
Microbially compromised wounds have been treated with different essential oils, honey, cationic 
peptides, aloe vera, plant extracts, and other natural occurring antimicrobial, anti-inflammatory, and 
regenerative molecules but the available evidence is limited and insufficient to be able to draw reliable 
conclusions and to extrapolate those findings to the clinical practice. Instead of talking about the 
beneficial or inert effects of those natural occurring materials the scientific community directs towards 
the identification of the main active components involved and their mechanism of action during the 
healing, antimicrobial, or regenerative processes and in carrying out systematic and comparative 
controlled tests. For many of those components the scientific basis behind which support the beneficial 
effect at a molecular level still needs to be addressed. The evidence and some promising preliminary 
results indicate that future comparative studies are justified. However, some of the clinical trials reported 
are biased due to the lack of methodology during the tests. Also, several factors that have not been, in 
many cases, previously considered should be taking into account in those future studies including the 
healing kinetics, the wound type, chronicity, the moment to apply the therapeutic compound, the 
condition of the patients, origin, age, combinatory effects, contact time, the bacterial strain present, etc. 
Double-blinded multi-center randomized placebo-controlled trials are needed to reach a sufficient level 
of evidence and to generate new practices to extrapolate those findings to the clinical practice. 
The modification of commercial dressing with essential oils and honey has proven to provide them 
with bactericidal and antifungal properties that would favor the wound healing process. However, these 
materials cannot solve the problem of the high volatility of the EOs that severely limit the effectiveness 
of the dressing. Some attempts to increase the stability of EOs were carried out using magnetic 
nanoparticles to anchor them to the dressing showing good results. A more effective way to control the 
releasing of the bioactive compounds necessary to the healing process of different wounds and/or at 
different wound stages would be the encapsulation in the polymeric matrix constituting the dressings. 
  
Materials 2015, 8 5181 
 
 
Acknowledgments 
Financial support from the EU thanks to the ERC Consolidator Grant program (ERC-2013-CoG-614715, 
NANOHEDONISM) is gratefully acknowledged. CIBER-BBN is an initiative funded by the VI National 
R&D&i Plan 2008–2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and financed 
by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund.  
We thank Ivan Moreno and Javier Aragon for providing Figures 4 and 5. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Borena, B.M.; Martens, A.; Broeckx, S.Y.; Meyer, E.; Chiers, K.; Duchateau, L.; Spaas, J.H. 
Regenerative skin wound healing in mammals: State-of-the-art on growth factor and stem cell 
based treatments. Cell. Physiol. Biochem. 2015, 36, 1–23. 
2. Martin, P. Wound healing—Aiming for perfect skin regeneration. Science 1997, 276, 75–81. 
3. Proksch, E.; Brandner, J.M.; Jensen, J.-M. The skin: An indispensable barrier. Exp. Dermatol. 
2008, 17, 1063–1072. 
4. Sood, A.; Granick, M.S.; Tomaselli, N.L. Wound dressings and comparative effectiveness data. 
Adv. Wound Care 2014, 3, 511–529. 
5. Madison, K.C. Barrier function of the skin: “La raison d’être” of the epidermis. J. Invest. Dermatol. 
2003, 121, 231–241. 
6. Crovetti, G.; Martinelli, G.; Issi, M.; Barone, M.; Guizzardi, M.; Campanati, B.; Moroni, M.; 
Carabelli, A. Platelet gel for healing cutaneous chronic wounds. Transfus. Apher. Sci. 2004, 30, 
145–151. 
7. Lazarus, G.S.; Cooper, D.M.; Knighton, D.R.; Margolis, D.J.; Pecoraro, R.E.; Rodeheaver, G.; 
Robson, M.C. Definitions and guidelines for assessment of wounds and evaluation of healing. 
Arch. Dermatol. 1994, 130, 489–493. 
8. Nicks, B.A.; Ayello, E.A.; Woo, K.; Nitzki-George, D.; Sibbald, R.G. Acute wound management: 
Revisiting the approach to assessment, irrigation, and closure considerations. Int. J. Emerg. Med. 
2010, 3, 399–407. 
9. Sen, C.K.; Gordillo, G.M.; Roy, S.; Kirsner, R.; Lambert, L.; Hunt, T.K.; Gottrup, F.; Gurtner, G.C.; 
Longaker, M.T. Human skin wounds: A major and snowballing threat to public health and the 
economy. Wound Repair Regen. 2009, 17, 763–771. 
10. Posnett, J.; Gottrup, F.; Lundgren, H.; Saal, G. The resource impact of wounds on health-care 
providers in Europe. J. Wound Care 2009, 18, 154–161. 
11. Kim, D.J.; Mustoe, T.; Clark, R.A.F. Cutaneous wound healing in aging small mammals:  
A systematic review. Wound Repair Regen. 2015, 23, 318–339. 
12. The Burden of Wounds on EU Healthcare Systems. Available online: http://www.eucomed.org/ 
uploads/Modules/Publications/The%20Burden%20of%20Wounds%20on%20EU%20Healthcare% 
20Systems.pdf (accessed on 6 August 2015). 
Materials 2015, 8 5182 
 
 
13. Canadian Association of Wound Care. Available online: http://cawc.net/ (accessed on 6 August 2015). 
14. Wound Management: An $ 18.5 Billion+ Worldwide Market in 2021. Available online: http:// 
blog.mediligence.com/2013/06/10/wound-management-an-18-5-billion-worldwide-market-in-2021/ 
(accessed on 6 August 2015). 
15. Arnold, K.M.; Opdenaker, L.M.; Flynn, D.; Sims-Mourtada, J. Wound healing and cancer stem 
cells: Inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastasis 
2015, 8, 1–13. 
16. Guo, S.; Dipietro, L.A. Factors affecting wound healing. J. Dent. Res. 2010, 89, 219–229. 
17. Harding, K.G.; Morris, H.L.; Patel, G.K. Science, medicine and the future: Healing chronic 
wounds. BMJ 2002, 324, 160–163. 
18. Singer, A.J.; Clark, R.A. Cutaneous wound healing. N. Engl. J. Med. 1999, 341, 738–746. 
19. Eming, S.A.; Krieg, T.; Davidson, J.M. Inflammation in wound repair: Molecular and cellular 
mechanisms. J. Invest. Dermatol. 2007, 127, 514–525. 
20. Blanpain, C.; Fuchs, E. Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. 
Science 2014, 344, doi:10.1126/science.1242281. 
21. Werner, S.; Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 
2003, 83, 835–870. 
22. Gurtner, G.C.; Werner, S.; Barrandon, Y.; Longaker, M.T. Wound repair and regeneration.  
Nature 2008, 453, 314–321. 
23. Uccioli, L.; Izzo, V.; Meloni, M.; Vainieri, E.; Ruotolo, V.; Giurato, L. Non-healing foot ulcers in 
diabetic patients: General and local interfering conditions and management options with advanced 
wound dressings. J. Wound Care 2015, 24, 35–42. 
24. Stadelmann, W.K.; Digenis, A.G.; Tobin, G.R. Physiology and healing dynamics of chronic 
cutaneous wounds. Am. J. Surg. 1998, 176, 26S–38S. 
25. Galiano, R.D.; Tepper, O.M.; Pelo, C.R.; Bhatt, K.A.; Callaghan, M.; Bastidas, N.; Bunting, S.; 
Steinmetz, H.G.; Gurtner, G.C. Topical vascular endothelial growth factor accelerates diabetic 
wound healing through increased angiogenesis and by mobilizing and recruiting bone  
marrow-derived cells. Am. J. Pathol. 2004, 164, 1935–1947. 
26. Greaves, N.S.; Ashcroft, K.J.; Baguneid, M.; Bayat, A. Current understanding of molecular and 
cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J. Dermatol. Sci. 
2013, 72, 206–217. 
27. Risau, W. Mechanisms of angiogenesis. Nature 1997, 386, 671–674. 
28. Drinkwater, S.L.; Burnand, K.G.; Ding, R.; Smith, A. Increased but ineffectual angiogenic drive 
in nonhealing venous leg ulcers. J. Vasc. Surg. 2003, 38, 1106–1112. 
29. Athanasopoulos, A.N.; Economopoulou, M.; Orlova, V.V.; Sobke, A.; Schneider, D.; Weber, H.; 
Augustin, H.G.; Eming, S.A.; Schubert, U.; Linn, T.; et al. The extracellular adherence protein 
(Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair 
mechanisms. Blood 2006, 107, 2720–2727. 
30. Chavakis, T.; Hussain, M.; Kanse, S.M.; Peters, G.; Bretzel, R.G.; Flock, J.-I.; Herrmann, M.; 
Preissner, K.T. Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory 
factor by inhibiting the recruitment of host leukocytes. Nat. Med. 2002, 8, 687–693. 
31. Edwards, R.; Harding, K.G. Bacteria and wound healing. Curr. Opin. Infect. Dis. 2004, 17, 91–96. 
Materials 2015, 8 5183 
 
 
32. Leaper, D.; Assadian, O.; Edmiston, C.E. Approach to chronic wound infections. Br. J. Dermatol. 
2015, doi:10.1111/bjd.13677. 
33. Schultz, G.S.; Sibbald, R.G.; Falanga, V.; Ayello, E.A.; Dowsett, C.; Harding, K.; Romanelli, M.; 
Stacey, M.C.; Teot, L.; Vanscheidt, W. Wound bed preparation: A systematic approach to wound 
management. Wound Repair Regen. 2003, 11, S1–S28. 
34. Stojadinovic, A.; Carlson, J.W.; Schultz, G.S.; Davis, T.A.; Elster, E.A. Topical advances in wound 
care. Gynecol. Oncol. 2008, 111, S70–S80. 
35. Strohal, R.; Dissemond, J.; Jordan O’Brien, J.; Piaggesi, A.; Rimdeika, R.; Young, T.; Apelqvist,  J. 
EWMA Document: Debridement. J. Wound Care 2013, 22, S1–S52. 
36. World Union of Wound Healing Societies (WUWHS). Principles of Best Practice: Wound 
Infection in Clinical Practice. An International Consensus; MEP Ltd.: London, UK, 2008.  
37. Leaper, D.J.; Schultz, G.; Carville, K.; Fletcher, J.; Swanson, T.; Drake, R. Extending the TIME 
concept: What have we learned in the past 10 years? Int. Wound J. 2012, 9, 1–19. 
38. Edwards-Jones, V.; Buck, R.; Shawcross, S.G.; Dawson, M.M.; Dunn, K. The effect of essential oils 
on methicillin-resistant Staphylococcus aureus using a dressing model. Burns 2004, 30, 772–777. 
39. Romanelli, M.; Vowden, K.; Weir, D. Exudate management made easy. Wounds Int. 2010, 1, 1–5. 
40. Fonder, M.A.; Lazarus, G.S.; Cowan, D.A.; Aronson-Cook, B.; Kohli, A.R.; Mamelak, A.J. 
Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound 
care dressings. J. Am. Acad. Dermatol. 2008, 58, 185–206. 
41. Murphy, P.S.; Evans, G.R.D. Advances in wound healing: A review of current wound healing 
products. Plast. Surg. Int. 2012, 2012, doi:10.1155/2012/190436. 
42. Lazic, T.; Falanga, V. Bioengineered skin constructs and their use in wound healing. Plast. 
Reconstr. Surg. 2011, 127, 75S–90S. 
43. Vyas, K.; Vasconez, H. Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds. 
Healthcare 2014, 2, 356–400. 
44. Sussman, G.; Weller, C. Wound dressings update. J. Pharm. Pract. Res. 2006, 36, doi:10.1002/ 
j.2055-2335.2006.tb00640.x. 
45. Winter, G.D. Formation of the Scab and the Rate of Epithelization of Superficial Wounds in the 
Skin of the Young Domestic Pig. Nature 1962, 193, 293–294. 
46. Weller, C. Advanced Textiles for Wound Care; Elsevier: Cambridge, UK, 2009. 
47. Mayet, N.; Choonara, Y.E.; Kumar, P.; Tomar, L.K.; Tyagi, C.; Du Toit, L.C.; Pillay, V.  
A comprehensive review of advanced biopolymeric wound healing systems. J. Pharm. Sci. 2014, 
103, 2211–2230. 
48. Sharma, S.; Dua, A.; Malik, A. Third generation materials for wound dressings. Int. J. Pharm.  
Sci. Res. 2014, 5, 2113–2124. 
49. Zahedi, P.; Rezaeian, I.; Ranaei-Siadat, S.-O.; Jafari, S.-H.; Supaphol, P. A review on wound 
dressings with an emphasis on electrospun nanofibrous polymeric bandages. Polym. Adv. Technol. 
2010, 21, 77–95. 
50. Boateng, J.S.; Matthews, K.H.; Stevens, H.N.E.; Eccleston, G.M. Wound healing dressings and 
drug delivery systems: A review. J. Pharm. Sci. 2008, 97, 2892–2923. 
51. Seaman, S. Dressing selection in chronic wound management. J. Am. Podiatr. Med. Assoc. 2002, 
92, 24–33. 
Materials 2015, 8 5184 
 
 
52. GhavamiNejad, A.; Rajan Unnithan, A.; Ramachandra Kurup Sasikala, A.; Samarikhalaj, M.; 
Thomas, R.G.; Jeong, Y.Y.; Nasseri, S.; Murugesan, P.; Wu, D.; Hee Park, C.; et al. Mussel-Inspired 
Electrospun Nanofibers Functionalized with Size-Controlled Silver Nanoparticles for Wound 
Dressing Application. ACS Appl. Mater. Interfaces 2015, 7, 12176–12183. 
53. Huang, S.; Fu, X. Naturally derived materials-based cell and drug delivery systems in skin 
regeneration. J. Control. Release 2010, 142, 149–159. 
54. Norouzi, M.; Boroujeni, S.M.; Omidvarkordshouli, N.; Soleimani, M. Advances in Skin 
Regeneration: Application of Electrospun Scaffolds. Adv. Healthc. Mater. 2015, 4, 1114–1133. 
55. Ghica, M.V.; Albu, M.G.; Leca, M.; Popa, L.; Moisescu, S.T. Design and optimization of some 
collagen-minocycline based hydrogels potentially applicable for the treatment of cutaneous wound 
infections. Pharmazie 2011, 66, 853–861. 
56. Kempf, M.; Miyamura, Y.; Liu, P.-Y.; Chen, A.C.-H.; Nakamura, H.; Shimizu, H.; Tabata, Y.; 
Kimble, R.M.; McMillan, J.R. A denatured collagen microfiber scaffold seeded with human 
fibroblasts and keratinocytes for skin grafting. Biomaterials 2011, 32, 4782–4792. 
57. Mitra, T.; Sailakshmi, G.; Gnanamani, A.; Raja, S.T.K.; Thiruselvi, T.; Gowri, V.M.; Selvaraj, N.V.; 
Ramesh, G.; Mandal, A.B. Preparation and characterization of a thermostable and biodegradable 
biopolymers using natural cross-linker. Int. J. Biol. Macromol. 2011, 48, 276–285. 
58. Fullana, M.J.; Wnek, G.E. Electrospun collagen and its applications in regenerative medicine. 
Drug Deliv. Transl. Res. 2012, 2, 313–322. 
59. Powell, H.M.; Supp, D.M.; Boyce, S.T. Influence of electrospun collagen on wound contraction of 
engineered skin substitutes. Biomaterials 2008, 29, 834–843. 
60. Zhong, S.P.; Zhang, Y.Z.; Lim, C.T. Tissue scaffolds for skin wound healing and dermal 
reconstruction. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2, 510–525. 
61. Pham, C.; Greenwood, J.; Cleland, H.; Woodruff, P.; Maddern, G. Bioengineered skin substitutes 
for the management of burns: A systematic review. Burns 2007, 33, 946–957. 
62. Powell, H.M.; Boyce, S.T. Fiber density of electrospun gelatin scaffolds regulates morphogenesis 
of dermal-epidermal skin substitutes. J. Biomed. Mater. Res. A 2008, 84, 1078–1086. 
63. Bilgic, H.; Demiriz, M.; Ozler, M.; Ide, T.; Dogan, N.; Gumus, S.; Kiziltay, A.; Endogan, T.; 
Hasirci, V.; Hasirci, N. Gelatin Based Scaffolds and Effect of EGF Dose on Wound Healing.  
J. Biomater. Tissue Eng. 2013, 3, 205–211. 
64. Ahmed, T.A.E.; Dare, E.V.; Hincke, M. Fibrin: A versatile scaffold for tissue engineering 
applications. Tissue Eng. Part B Rev. 2008, 14, 199–215. 
65. Mogoşanu, G.D.; Grumezescu, A.M. Natural and synthetic polymers for wounds and burns 
dressing. Int. J. Pharm. 2014, 463, 127–136. 
66. Ulubayram, K.; Aksu, E.; Gurhan, S.I.D.; Serbetci, K.; Hasirci, N. Cytotoxicity evaluation of 
gelatin sponges prepared with different cross-linking agents. J. Biomater. Sci. Polym. Ed. 2002, 
13, 1203–1219. 
67. Panzavolta, S.; Gioffrè, M.; Focarete, M.L.; Gualandi, C.; Foroni, L.; Bigi, A. Electrospun gelatin 
nanofibers: Optimization of genipin cross-linking to preserve fiber morphology after exposure to 
water. Acta Biomater. 2011, 7, 1702–1709. 
68. Sisson, K.; Zhang, C.; Farach-Carson, M.C.; Chase, D.B.; Rabolt, J.F. Evaluation of cross-linking 
methods for electrospun gelatin on cell growth and viability. Biomacromolecules 2009, 10, 1675–1680. 
Materials 2015, 8 5185 
 
 
69. Torres-Giner, S.; Gimeno-Alcañiz, J.V.; Ocio, M.J.; Lagaron, J.M. Comparative performance of 
electrospun collagen nanofibers cross-linked by means of different methods. ACS Appl. Mater. 
Interfaces 2009, 1, 218–223. 
70. Dai, T.; Tanaka, M.; Huang, Y.-Y.; Hamblin, M.R. Chitosan preparations for wounds and burns: 
Antimicrobial and wound-healing effects. Expert Rev. Anti. Infect. Ther. 2011, 9, 857–879. 
71. Tchemtchoua, V.T.; Atanasova, G.; Aqil, A.; Filée, P.; Garbacki, N.; Vanhooteghem, O.; 
Deroanne, C.; Noël, A.; Jérome, C.; Nusgens, B.; et al. Development of a chitosan nanofibrillar 
scaffold for skin repair and regeneration. Biomacromolecules 2011, 12, 3194–3204. 
72. Pandima Devi, M.; Sekar, M.; Chamundeswari, M.; Moorthy, A.; Krithiga, G.; Murugan, N.S.; 
Sastry, T.P. A novel wound dressing material—Fibrin-chitosan-sodium alginate composite sheet. 
Bull. Mater. Sci. 2013, 35, 1157–1163. 
73. Leung, V.; Hartwell, R.; Elizei, S.S.; Yang, H.; Ghahary, A.; Ko, F. Postelectrospinning modifications 
for alginate nanofiber-based wound dressings. J. Biomed. Mater. Res. B. Appl. Biomater. 2014, 
102, 508–515. 
74. Park, S.A.; Park, K.E.; Kim, W. Preparation of sodium alginate/poly(ethylene oxide) blend 
nanofibers with lecithin. Macromol. Res. 2010, 18, 891–896. 
75. Boateng, J.; Burgos-Amador, R.; Okeke, O.; Pawar, H. Composite alginate and gelatin based  
bio-polymeric wafers containing silver sulfadiazine for wound healing. Int. J. Biol. Macromol. 
2015, 79, 63–71. 
76. Uppal, R.; Ramaswamy, G.N.; Arnold, C.; Goodband, R.; Wang, Y. Hyaluronic acid nanofiber 
wound dressing—Production, characterization, and in vivo behavior. J. Biomed. Mater. Res. B 
Appl. Biomater. 2011, 97, 20–29. 
77. Collins, M.N.; Birkinshaw, C. Hyaluronic acid based scaffolds for tissue engineering—A review. 
Carbohydr. Polym. 2013, 92, 1262–1279. 
78. Neuman, M.G.; Nanau, R.M.; Oruña-Sanchez, L.; Coto, G. Hyaluronic acid and wound healing.  
J. Pharm. Pharm. Sci. 2015, 18, 53–60. 
79. Quan, R.; Zheng, X.; Xu, S.; Zhang, L.; Yang, D. Gelatin-chondroitin-6-sulfate-hyaluronic acid 
scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a 
three-dimensional skin substitute. Stem Cell Res. Ther. 2014, 5, doi:10.1186/scrt508. 
80. Zhang, L.-M.; Wu, C.-X.; Huang, J.-Y.; Peng, X.-H.; Chen, P.; Tang, S.-Q. Synthesis and 
characterization of a degradable composite agarose/HA hydrogel. Carbohydr. Polym. 2012, 88, 
1445–1452. 
81. Seidlits, S.K.; Drinnan, C.T.; Petersen, R.R.; Shear, J.B.; Suggs, L.J.; Schmidt, C.E.  
Fibronectin-hyaluronic acid composite hydrogels for three-dimensional endothelial cell culture. 
Acta Biomater. 2011, 7, 2401–2409. 
82. Nguyen, T.T.T.; Ghosh, C.; Hwang, S.-G.; Tran, L.D.; Park, J.S. Characteristics of curcumin-loaded 
poly (lactic acid) nanofibers for wound healing. J. Mater. Sci. 2013, 48, 7125–7133. 
83. Sekiya, N.; Ichioka, S.; Terada, D.; Tsuchiya, S.; Kobayashi, H. Efficacy of a poly glycolic acid 
(PGA)/collagen composite nanofibre scaffold on cell migration and neovascularisation in vivo skin 
defect model. J. Plast. Surg. Hand Surg. 2013, 47, 498–502. 
Materials 2015, 8 5186 
 
 
84. Ranjbar-Mohammadi, M.; Bahrami, S.H. Development of nanofibrous scaffolds containing gum 
tragacanth/poly (ε-caprolactone) for application as skin scaffolds. Mater. Sci. Eng. C Mater. Biol. 
Appl. 2015, 48, 71–79. 
85. Shahverdi, S.; Hajimiri, M.; Esfandiari, M.A.; Larijani, B.; Atyabi, F.; Rajabiani, A.; Dehpour, A.R.; 
Gharehaghaji, A.A.; Dinarvand, R. Fabrication and structure analysis of poly(lactide-co-glycolic 
acid)/silk fibroin hybrid scaffold for wound dressing applications. Int. J. Pharm. 2014, 473,  
345–355. 
86. Sun, X.; Cheng, L.; Zhu, W.; Hu, C.; Jin, R.; Sun, B.; Shi, Y.; Zhang, Y.; Cui, W. Use of 
ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound cover induces healing 
and inhibits hypertrophic scar formation of the skin. Colloids Surf. B Biointerfaces 2014, 115,  
61–70. 
87. Yari, A.; Yeganeh, H.; Bakhshi, H. Synthesis and evaluation of novel absorptive and antibacterial 
polyurethane membranes as wound dressing. J. Mater. Sci. Mater. Med. 2012, 23, 2187–2202. 
88. Unnithan, A.R.; Barakat, N.A.M.; Pichiah, P.B.T.; Gnanasekaran, G.; Nirmala, R.; Cha, Y.-S.; 
Jung, C.-H.; El-Newehy, M.; Kim, H.Y. Wound-dressing materials with antibacterial activity from 
electrospun polyurethane-dextran nanofiber mats containing ciprofloxacin HCl. Carbohydr. Polym. 
2012, 90, 1786–1793. 
89. Dai, X.-Y.; Nie, W.; Wang, Y.-C.; Shen, Y.; Li, Y.; Gan, S.-J. Electrospun emodin 
polyvinylpyrrolidone blended nanofibrous membrane: A novel medicated biomaterial for drug 
delivery and accelerated wound healing. J. Mater. Sci. Mater. Med. 2012, 23, 2709–2716. 
90. Yun, E.J.; Yon, B.; Joo, M.K.; Jeong, B. Cell therapy for skin wound using fibroblast encapsulated 
poly(ethylene glycol)-poly(L-alanine) thermogel. Biomacromolecules 2012, 13, 1106–1111. 
91. Sinha, M.; Banik, R.M.; Haldar, C.; Maiti, P. Development of ciprofloxacin hydrochloride loaded 
poly(ethylene glycol)/chitosan scaffold as wound dressing. J. Porous Mater. 2012, 20, 799–807. 
92. Elsner, J.J.; Kraitzer, A.; Grinberg, O.; Zilberman, M. Highly porous drug-eluting structures: From 
wound dressings to stents and scaffolds for tissue regeneration. Biomatter 2012, 2, 239–270. 
93. Reilly, G.C.; Engler, A.J. Intrinsic extracellular matrix properties regulate stem cell differentiation. 
J. Biomech. 2010, 43, 55–62. 
94. Théry, M. Micropatterning as a tool to decipher cell morphogenesis and functions. J. Cell Sci. 
2010, 123, 4201–4213. 
95. Yannas, I.V. Tissue regeneration by use of collagen-glycosaminoglycan copolymers. Clin. Mater. 
1992, 9, 179–187. 
96. Chevalier, E.; Chulia, D.; Pouget, C.; Viana, M. Fabrication of porous substrates: A review of 
processes using pore forming agents in the biomaterial field. J. Pharm. Sci. 2008, 97, 1135–1154. 
97. Elsner, J.J.; Zilberman, M. Antibiotic-eluting bioresorbable composite fibers for wound healing 
applications: Microstructure, drug delivery and mechanical properties. Acta Biomater. 2009, 5, 
2872–2883. 
98. Hu, X.; Liu, S.; Zhou, G.; Huang, Y.; Xie, Z.; Jing, X. Electrospinning of polymeric nanofibers for 
drug delivery applications. J. Control. Release 2014, 185, 12–21. 
99. Garg, T.; Singh, O.; Arora, S.; Murthy, R. Scaffold: A novel carrier for cell and drug delivery.  
Crit. Rev. Ther. Drug Carrier Syst. 2012, 29, 1–63. 
Materials 2015, 8 5187 
 
 
100. Yin, A.; Zhang, K.; McClure, M.J.; Huang, C.; Wu, J.; Fang, J.; Mo, X.; Bowlin, G.L.; Al-Deyab, S.S.; 
El-Newehy, M. Electrospinning collagen/chitosan/poly(L-lactic acid-co-ε-caprolactone) to form a 
vascular graft: Mechanical and biological characterization. J. Biomed. Mater. Res. A 2013, 101, 
1292–1301. 
101. Bhardwaj, N.; Kundu, S.C. Electrospinning: A fascinating fiber fabrication technique.  
Biotechnol. Adv. 2010, 28, 325–347. 
102. Choi, J.S.; Leong, K.W.; Yoo, H.S. In vivo wound healing of diabetic ulcers using electrospun 
nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 2008, 29,  
587–596. 
103. Zamani, M.; Prabhakaran, M.P.; Ramakrishna, S. Advances in drug delivery via electrospun and 
electrosprayed nanomaterials. Int. J. Nanomed. 2013, 8, 2997–3017. 
104. Cui, W.; Li, X.; Zhou, S.; Weng, J. Investigation on process parameters of electrospinning system 
through orthogonal experimental design. J. Appl. Polym. Sci. 2007, 103, 3105–3112. 
105. Yoo, H.S.; Kim, T.G.; Park, T.G. Surface-functionalized electrospun nanofibers for tissue 
engineering and drug delivery. Adv. Drug Deliv. Rev. 2009, 61, 1033–1042. 
106. Zou, B.; Liu, Y.; Luo, X.; Chen, F.; Guo, X.; Li, X. Electrospun fibrous scaffolds with continuous 
gradations in mineral contents and biological cues for manipulating cellular behaviors.  
Acta Biomater. 2012, 8, 1576–1585. 
107. Ma, G.; Liu, Y.; Peng, C.; Fang, D.; He, B.; Nie, J. Paclitaxel loaded electrospun porous nanofibers 
as mat potential application for chemotherapy against prostate cancer. Carbohydr. Polym. 2011, 
86, 505–512. 
108. Matthews, J.A.; Wnek, G.E.; Simpson, D.G.; Bowlin, G.L. Electrospinning of Collagen 
Nanofibers. Biomacromolecules 2002, 3, 232–238. 
109. Toshkova, R.; Manolova, N.; Gardeva, E.; Ignatova, M.; Yossifova, L.; Rashkov, I.; Alexandrov, M. 
Antitumor activity of quaternized chitosan-based electrospun implants against Graffi myeloid 
tumor. Int. J. Pharm. 2010, 400, 221–233. 
110. Um, I.C.; Fang, D.; Hsiao, B.S.; Okamoto, A.; Chu, B. Electro-spinning and electro-blowing of 
hyaluronic acid. Biomacromolecules 2004, 5, 1428–1436. 
111. Vargas, E.A.T.; do Vale Baracho, N.C.; de Brito, J.; de Queiroz, A.A.A. Hyperbranched polyglycerol 
electrospun nanofibers for wound dressing applications. Acta Biomater. 2010, 6, 1069–1078. 
112. Yang, F.; Murugan, R.; Wang, S.; Ramakrishna, S. Electrospinning of nano/micro scale  
poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 
2005, 26, 2603–2610. 
113. Zong, X.; Li, S.; Chen, E.; Garlick, B.; Kim, K.-S.; Fang, D.; Chiu, J.; Zimmerman, T.; Brathwaite, C.; 
Hsiao, B.S.; et al. Prevention of postsurgery-induced abdominal adhesions by electrospun bioabsorbable 
nanofibrous poly(lactide-co-glycolide)-based membranes. Ann. Surg. 2004, 240, 910–915. 
114. Spasova, M.; Paneva, D.; Manolova, N.; Radenkov, P.; Rashkov, I. Electrospun chitosan-coated 
fibers of poly(L-lactide) and poly(L-lactide)/poly(ethylene glycol): Preparation and characterization. 
Macromol. Biosci. 2008, 8, 153–162. 
115. Rho, K.S.; Jeong, L.; Lee, G.; Seo, B.-M.; Park, Y.J.; Hong, S.-D.; Roh, S.; Cho, J.J.; Park, W.H.; 
Min, B.-M. Electrospinning of collagen nanofibers: Effects on the behavior of normal human 
keratinocytes and early-stage wound healing. Biomaterials 2006, 27, 1452–1461. 
Materials 2015, 8 5188 
 
 
116. Endres, T.; Zheng, M.; Beck-Broichsitter, M.; Samsonova, O.; Debus, H.; Kissel, T. Optimising 
the self-assembly of siRNA loaded PEG-PCL-lPEI nano-carriers employing different preparation 
techniques. J. Control. Release 2012, 160, 583–591. 
117. Paquay, Y.C.; de Ruijter, A.E.; van der Waerden, J.P.; Jansen, J.A. A one stage versus two stage 
surgical technique. Tissue reaction to a percutaneous device provided with titanium fiber mesh 
applicable for peritoneal dialysis. ASAIO J. 1996, 42, 961–967. 
118. Garg, T.; Singh, S.; Goyal, A.K. Stimuli-sensitive hydrogels: An excellent carrier for drug and cell 
delivery. Crit. Rev. Ther. Drug Carrier Syst. 2013, 30, 369–409. 
119. Kenawy, E.-R.; Bowlin, G.L.; Mansfield, K.; Layman, J.; Simpson, D.G.; Sanders, E.H.; Wnek, G.E. 
Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic 
acid), and a blend. J. Control. Release 2002, 81, 57–64. 
120. Kost, J.; Langer, R. Responsive polymeric delivery systems. Adv. Drug Deliv. Rev. 2001, 46,  
125–148. 
121. Jannesari, M.; Varshosaz, J.; Morshed, M.; Zamani, M. Composite poly(vinyl alcohol)/poly(vinyl 
acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of 
drugs. Int. J. Nanomed. 2011, 6, 993–1003. 
122. Garg, T.; Goyal, A.K. Biomaterial-based scaffolds—Current status and future directions.  
Expert Opin. Drug Deliv. 2014, 11, 767–789. 
123. Luo, X.; Xie, C.; Wang, H.; Liu, C.; Yan, S.; Li, X. Antitumor activities of emulsion electrospun 
fibers with core loading of hydroxycamptothecin via intratumoral implantation. Int. J. Pharm. 
2012, 425, 19–28. 
124. Zeng, J.; Xu, X.; Chen, X.; Liang, Q.; Bian, X.; Yang, L.; Jing, X. Biodegradable electrospun fibers 
for drug delivery. J. Control. Release 2003, 92, 227–231. 
125. Meng, Z.X.; Xu, X.X.; Zheng, W.; Zhou, H.M.; Li, L.; Zheng, Y.F.; Lou, X. Preparation and 
characterization of electrospun PLGA/gelatin nanofibers as a potential drug delivery system. 
Colloids Surf. B Biointerfaces 2011, 84, 97–102. 
126. Qi, M.; Li, X.; Yang, Y.; Zhou, S. Electrospun fibers of acid-labile biodegradable polymers 
containing ortho ester groups for controlled release of paracetamol. Eur. J. Pharm. Biopharm. 
2008, 70, 445–452. 
127. Rujitanaroj, P.; Wang, Y.-C.; Wang, J.; Chew, S.Y. Nanofiber-mediated controlled release of 
siRNA complexes for long term gene-silencing applications. Biomaterials 2011, 32, 5915–5923. 
128. Kim, H.S.; Yoo, H.S. MMPs-responsive release of DNA from electrospun nanofibrous matrix for 
local gene therapy: In vitro and in vivo evaluation. J. Control. Release 2010, 145, 264–271. 
129. Liao, I.-C.; Chen, S.; Liu, J.B.; Leong, K.W. Sustained viral gene delivery through core-shell 
fibers. J. Control. Release 2009, 139, 48–55. 
130. Said, S.S.; Aloufy, A.K.; El-Halfawy, O.M.; Boraei, N.A.; El-Khordagui, L.K. Antimicrobial PLGA 
ultrafine fibers: Interaction with wound bacteria. Eur. J. Pharm. Biopharm. 2011, 79, 108–118. 
131. Yun, J.; Im, J.S.; Lee, Y.-S.; Kim, H.-I. Electro-responsive transdermal drug delivery behavior of 
PVA/PAA/MWCNT nanofibers. Eur. Polym. J. 2011, 47, 1893–1902. 
132. Suwantong, O.; Opanasopit, P.; Ruktanonchai, U.; Supaphol, P. Electrospun cellulose acetate fiber 
mats containing curcumin and release characteristic of the herbal substance. Polymer 2007, 48, 
7546–7557. 
Materials 2015, 8 5189 
 
 
133. Yang, Y.; Xia, T.; Zhi, W.; Wei, L.; Weng, J.; Zhang, C.; Li, X. Promotion of skin regeneration in 
diabetic rats by electrospun core-sheath fibers loaded with basic fibroblast growth factor. 
Biomaterials 2011, 32, 4243–4254. 
134. Anghel, I.; Holban, A.M.; Grumezescu, A.M.; Andronescu, E.; Ficai, A.; Anghel, A.G.; Maganu, M.; 
Lazǎr, V.; Chifiriuc, M.C. Modified wound dressing with phyto-nanostructured coating to  
prevent staphylococcal and pseudomonal biofilm development. Nanoscale Res. Lett. 2012, 7, 
doi:10.1186/1556-276X-7-690. 
135. Anghel, I.; Holban, A.M.; Andronescu, E.; Grumezescu, A.M.; Chifiriuc, M.C. Efficient surface 
functionalization of wound dressings by a phytoactive nanocoating refractory to Candida albicans 
biofilm development. Biointerphases 2013, 8, doi:10.1186/1559-4106-8-12. 
136. World Union of Wound Healing Societies. Wound Infection in Clinical Practice; Medical 
Education Partnership Ltd.: London, UK, 2008. 
137. Israili, Z.H. Antimicrobial properties of honey. Am. J. Ther. 2014, 21, 304–323. 
138. Gethin, G.; Cowman, S. Manuka honey vs. hydrogel—A prospective, open label, multicentre, 
randomised controlled trial to compare desloughing efficacy and healing outcomes in venous 
ulcers. J. Clin. Nurs. 2009, 18, 466–474. 
139. Jull, A.; Walker, N.; Parag, V.; Molan, P.; Rodgers, A. Randomized clinical trial of honey-
impregnated dressings for venous leg ulcers. Br. J. Surg. 2008, 95, 175–182. 
140. Gethin, G.; Cowman, S. Bacteriological changes in sloughy venous leg ulcers treated with manuka 
honey or hydrogel: An RCT. J. Wound Care 2008, 17, 246–247. 
141. Lund-Nielsen, B.; Adamsen, L.; Kolmos, H.J.; Rørth, M.; Tolver, A.; Gottrup, F. The effect of 
honey-coated bandages compared with silver-coated bandages on treatment of malignant  
wounds-a randomized study. Wound Repair Regen. 2011, 19, 664–670. 
142. Gulati, S.; Qureshi, A.; Srivastava, A.; Kataria, K.; Kumar, P.; Ji, A.B. A Prospective Randomized 
Study to Compare the Effectiveness of Honey Dressing vs. Povidone Iodine Dressing in Chronic 
Wound Healing. Indian J. Surg. 2014, 76, 193–198. 
143. Kamaratos, A.V.; Tzirogiannis, K.N.; Iraklianou, S.A.; Panoutsopoulos, G.I.; Kanellos, I.E.; 
Melidonis, A.I. Manuka honey-impregnated dressings in the treatment of neuropathic diabetic  
foot ulcers. Int. Wound J. 2014, 11, 259–263. 
144. Udwadia, T.E. Ghee and honey dressing for infected wounds. Indian J. Surg. 2011, 73, 278–283. 
145. Majtan, J. Methylglyoxal—A potential risk factor of manuka honey in healing of diabetic ulcers. 
Evidence-Based Complement. Altern. Med. 2011, 2011, doi:10.1093/ecam/neq013. 
146. Robson, V.; Yorke, J.; Sen, R.A.; Lowe, D.; Rogers, S.N. Randomised controlled feasibility trial 
on the use of medical grade honey following microvascular free tissue transfer to reduce the 
incidence of wound infection. Br. J. Oral Maxillofac. Surg. 2012, 50, 321–327. 
147. Olajuyigbe, O.; Ashafa, A. Chemical Composition and Antibacterial Activity of Essential Oil  
of Cosmos bipinnatus Cav. Leaves from South Africa. Iran. J. Pharm. Res. IJPR 2014, 13,  
1417–1423. 
148. Hammer, K.A.; Carson, C.F.; Riley, T.V. Effects of Melaleuca alternifolia (tea tree) essential oil 
and the major monoterpene component terpinen-4-ol on the development of single- and multistep 
antibiotic resistance and antimicrobial susceptibility. Antimicrob. Agents Chemother. 2012, 56, 
909–915. 
Materials 2015, 8 5190 
 
 
149. Walsh, S.E.; Maillard, J.-Y.; Russell, A.D.; Catrenich, C.E.; Charbonneau, D.L.; Bartolo, R.G. 
Development of bacterial resistance to several biocides and effects on antibiotic susceptibility.  
J. Hosp. Infect. 2003, 55, 98–107. 
150. Darmstadt, G.L.; Saha, S.K.; Ahmed, A.S.M.N.U.; Chowdhury, M.A.K.A.; Law, P.A.; Ahmed, S.; 
Alam, M.A.; Black, R.E.; Santosham, M. Effect of topical treatment with skin barrier-enhancing 
emollients on nosocomial infections in preterm infants in Bangladesh: A randomised controlled 
trial. Lancet 2005, 365, 1039–1045. 
151. Dryden, M.S.; Dailly, S.; Crouch, M. A randomized, controlled trial of tea tree topical preparations 
versus a standard topical regimen for the clearance of MRSA colonization. J. Hosp. Infect. 2004, 
56, 283–286. 
152. Blackwood, B.; Thompson, G.; McMullan, R.; Stevenson, M.; Riley, T.V; Alderdice, F.A.; 
Trinder, T.J.; Lavery, G.G.; McAuley, D.F. Tea tree oil (5%) body wash versus standard care 
(Johnson’s Baby Softwash) to prevent colonization with methicillin-resistant staphylococcus 
aureus in critically ill adults: A randomized controlled trial. J. Antimicrob. Chemother. 2013, 68, 
1193–1199. 
153. Casetti, F.; Bartelke, S.; Biehler, K.; Augustin, M.; Schempp, C.M.; Frank, U. Antimicrobial 
activity against bacteria with dermatological relevance and skin tolerance of the essential oil from 
Coriandrum sativum L. fruits. Phytother. Res. 2012, 26, 420–424. 
154. Altaei, D.T. Topical lavender oil for the treatment of recurrent aphthous ulceration. Am. J. Dent. 
2012, 25, 39–43. 
155. Giuliani, A.; Pirri, G.; Nicoletto, S.F. Antimicrobial peptides: An overview of a promising class of 
therapeutics. Cent. Eur. J. Biol. 2007, 2, 1–33. 
156. Niyonsaba, F.; Ogawa, H. Protective roles of the skin against infection: Implication of  
naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. 
J. Dermatol. Sci. 2005, 40, 157–168. 
157. Korting, H.C.; Schöllmann, C.; Stauss-Grabo, M.; Schäfer-Korting, M. Antimicrobial peptides and 
skin: A paradigm of translational medicine. Skin Pharmacol. Physiol. 2012, 25, 323–334. 
158. Lipsky, B.A.; Holroyd, K.J.; Zasloff, M. Topical versus systemic antimicrobial therapy for treating 
mildly infected diabetic foot ulcers: A randomized, controlled, double-blinded, multicenter trial of 
pexiganan cream. Clin. Infect. Dis. 2008, 47, 1537–1545. 
159. Wiezer, M.J.; Boelens, P.G.; Vuylsteke, R.J.; Nijveldt, R.J.; Meijer, C.; Cuesta, M.A.; Meijer, S.; 
van Leeuwen, P.A. Perioperative treatment with bactericidal/permeability-increasing protein 
(rBPI21) in major liver surgery: A concise summary. Ann. Acad. Med. Singap. 2001, 30, 226–233. 
160. Alexander, S.; Bramson, J.; Foley, R.; Xing, Z. Protection from endotoxemia by adenoviral-mediated 
gene transfer of human bactericidal/permeability-increasing protein. Blood 2004, 103, 93–99. 
161. Livermore, D.M. Bacterial resistance: Origins, epidemiology, and impact. Clin. Infect. Dis. 2003, 
36, S11–S23. 
162. Furuya, E.Y.; Lowy, F.D. Antimicrobial-resistant bacteria in the community setting. Nat. Rev. 
Microbiol. 2006, 4, 36–45. 
163. Proykova, A. Opinion on Nanosilver: Safety, Health and Environmental Effects and Role in 
Antimicrobial Resistance; European Commission: Luxembourg City, Luxembourg, 2014. 
Materials 2015, 8 5191 
 
 
164. Koh, K.J.; Pearce, A.L.; Marshman, G.; Finlay-Jones, J.J.; Hart, P.H. Tea tree oil reduces 
histamine-induced skin inflammation. Br. J. Dermatol. 2002, 147, 1212–1217. 
165. Javed, F.; Al-Hezaimi, K.; Romanos, G.E. Role of dentifrices with essential oil formulations in 
periodontal healing. Am. J. Med. Sci. 2012, 343, 411–417. 
166. Reddy, R.L.; Reddy, R.S.; Ramesh, T.; Singh, T.R.; Swapna, L.A.; Laxmi, N.V. Randomized trial 
of aloe vera gel vs. triamcinolone acetonide ointment in the treatment of oral lichen planus. 
Quintessence Int. 2012, 43, 793–800. 
167. Lalićević, S.; Djordjević, I. Comparison of benzydamine hydrochloride and Salvia officinalis as 
an adjuvant local treatment to systemic nonsteroidal anti-inflammatory drug in controlling pain 
after tonsillectomy, adenoidectomy, or both: An open-label, single-blind, randomized clinical. 
Curr. Ther. Res. Clin. Exp. 2004, 65, 360–372. 
168. Vakilian, K.; Atarha, M.; Bekhradi, R.; Chaman, R. Healing advantages of lavender essential oil 
during episiotomy recovery: A clinical trial. Complement. Ther. Clin. Pract. 2011, 17, 50–53. 
169. Behmanesh, F.; Tofighi, M.; Delavar, M.A.; Zeinalzadeh, M.; Moghadamnia, A.A.; Khafri, S.  
A Clinical trial to compare the effectiveness of Lavender essential oil and olive oil at healing 
postpartum mother’s perinea. Healthmed 2011, 5, 1512–1516. 
170. Eghdampour, F.; Jahdie, F.; Kheyrkhah, M.; Taghizadeh, M.; Naghizadeh, S.; Hagani, H. The 
Impact of Aloe vera and Calendula on Perineal Healing after Episiotomy in Primiparous Women: 
A Randomized Clinical Trial. J. Caring Sci. 2013, 2, 279–286. 
171. Tripathy, R.N.; Otta, S.P.; Siddram, A. Bala taila parisheka—A traditional approach in wound 
healing. Indian J. Tradit. Knowl. 2011, 10, 643–650. 
172. Maenthaisong, R.; Chaiyakunapruk, N.; Niruntraporn, S.; Kongkaew, C. The efficacy of aloe vera 
used for burn wound healing: A systematic review. Burns 2007, 33, 713–718. 
173. Gallagher, J.; Gray, M. Is aloe vera effective for healing chronic wounds? J. Wound. Ostomy 
Continence Nurs. 2003, 30, 68–71. 
174. Molazem, Z.; Mohseni, F.; Younesi, M.; Keshavarzi, S. Aloe vera gel and cesarean wound healing; 
a randomized controlled clinical trial. Glob. J. Health Sci. 2015, 7, 203–239. 
175. Rahmani, N.; Khademloo, M.; Vosoughi, K.; Assadpour, S. Effects of Aloe vera cream on chronic 
anal fissure pain, wound healing and hemorrhaging upon defection: A prospective double blind 
clinical trial. Eur. Rev. Med. Pharmacol. Sci. 2014, 18, 1078–1084. 
176. Shahzad, M.N.; Ahmed, N. Effectiveness of Aloe Vera gel compared with 1% silver sulphadiazine 
cream as burn wound dressing in second degree burns. J. Pak. Med. Assoc. 2013, 63, 225–230. 
177. Samet, N.; Laurent, C.; Susarla, S.M.; Samet-Rubinsteen, N. The effect of bee propolis on recurrent 
aphthous stomatitis: A pilot study. Clin. Oral Investig. 2007, 11, 143–147. 
178. Mohajeri, G.; Safaee, M.; Sanei, M.H. Effects of topical Kiwifruit on healing of neuropathic 
diabetic foot ulcer. J. Res. Med. Sci. 2014, 19, 520–524. 
179. Romero-Cerecero, O.; Zamilpa-Álvarez, A.; Jiménez-Ferrer, E.; Tortoriello, J. Exploratory study 
on the effectiveness of a standardized extract from Ageratina pichinchensis in patients with chronic 
venous leg ulcers. Planta Med. 2012, 78, 304–310. 
180. Sivamani, R.K.; Ma, B.R.; Wehrli, L.N.; Maverakis, E. Phytochemicals and Naturally Derived 
Substances for Wound Healing. Adv. Wound Care 2012, 1, 213–217. 
Materials 2015, 8 5192 
 
 
181. Tan, H.T.; Rahman, R.A.; Gan, S.H.; Halim, A.S.; Hassan, S.A.; Sulaiman, S.A.; Kirnpal-Kaur, B. 
The antibacterial properties of Malaysian tualang honey against wound and enteric  
microorganisms in comparison to manuka honey. BMC Complement. Altern. Med. 2009, 9, 
doi:10.1186/1472-6882-9-34. 
182. Henriques, A.F.; Jenkins, R.E.; Burton, N.F.; Cooper, R.A. The intracellular effects of manuka 
honey on Staphylococcus aureus. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29, 45–50. 
183. Maddocks, S.E.; Lopez, M.S.; Rowlands, R.S.; Cooper, R.A. Manuka honey inhibits the 
development of Streptococcus pyogenes biofilms and causes reduced expression of two fibronectin 
binding proteins. Microbiology 2012, 158, 781–790. 
184. Badet, C.; Quero, F. The in vitro effect of manuka honeys on growth and adherence of oral bacteria. 
Anaerobe 2011, 17, 19–22. 
185. Rahman, M.M.; Richardson, A.; Sofian-Azirun, M. Antibacterial activity of propolis and honey 
against staphylococcus aureus and escherichia coli. African J. Microbiol. Res. 2010, 4, 1872–1878. 
186. Zainol, M.I.; Mohd Yusoff, K.; Mohd Yusof, M.Y. Antibacterial activity of selected Malaysian 
honey. BMC Complement. Altern. Med. 2013, 13, doi:10.1186/1472-6882-13-129. 
187. Koburger, T.; Hübner, N.-O.; Braun, M.; Siebert, J.; Kramer, A. Standardized comparison of 
antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and 
chlorhexidine digluconate. J. Antimicrob. Chemother. 2010, 65, 1712–1719. 
188. Dryden, M.; Lockyer, G.; Saeed, K.; Cooke, J. Engineered honey: In vitro antimicrobial activity 
of a novel topical wound care treatment. J. Glob. Antimicrob. Resist. 2014, 2, 168–172. 
189. Liakos, I.; Rizzello, L.; Hajiali, H.; Brunetti, V.; Carzino, R.; Pompa, P.P.; Athanassiou, A.; Mele, E. 
Fibrous wound dressings encapsulating essential oils as natural antimicrobial agents. J. Mater. 
Chem. B 2015, 3, 1583–1589.  
190. Chin, K.B.; Cordell, B. The effect of tea tree oil (Melaleuca alternifolia) on wound healing using 
a dressing model. J. Altern. Complement. Med. 2013, 19, 942–945. 
191. Muthaiyan, A.; Biswas, D.; Crandall, P.G.; Wilkinson, B.J.; Ricke, S.C. Application of orange 
essential oil as an antistaphylococcal agent in a dressing model. BMC Complement. Altern. Med. 
2012, 12, doi:10.1186/1472-6882-12-125. 
192. Budzyńska, A.; Sadowska, B.; Wieckowska-Szakiel, M.; Rózalska, B. In vitro efficacy analysis of 
absorbent dressing modified with essential oils, against Staphylococcus aureus and Candida 
albicans. Med. Dosw. Mikrobiol. 2013, 65, 77–86. 
193. Anghel, I.; Grumezescu, A.M.; Holban, A.M.; Ficai, A.; Anghel, A.G.; Chifiriuc, M.C. Biohybrid 
nanostructured iron oxide nanoparticles and Satureja hortensis to prevent fungal biofilm development. 
Int. J. Mol. Sci. 2013, 14, 18110–18123. 
194. Holban, A.M.; Grumezescu, A.M.; Ficai, A.; Chifiriuc, C.M.; Lazar, V.; Radulescu, R. 
Fe3O4@C18-carvone to prevent Candida tropicalis biofilm development. Rom. J. Mater. 2013, 
43, 300–305. 
195. Riella, K.R.; Marinho, R.R.; Santos, J.S.; Pereira-Filho, R.N.; Cardoso, J.C.; Thomazzi, S.M.; 
Albuquerque-Junior, R.L.C. Anti-inflammatory and cicatrizing activities of thymol, a monoterpene 
of the essential oil from Lippia gracilis, in rodents. J. Ethnopharmacol. 2012, 143, 656–663. 
Materials 2015, 8 5193 
 
 
196. Kavoosi, G.; Dadfar, S.M.M.; Purfard, A.M. Mechanical, physical, antioxidant, and antimicrobial 
properties of gelatin films incorporated with thymol for potential use as nano wound dressing.  
J. Food Sci. 2013, 78, E244–E250. 
197. Altiok, D.; Altiok, E.; Tihminlioglu, F. Physical, antibacterial and antioxidant properties of 
chitosan films incorporated with thyme oil for potential wound healing applications. J. Mater. Sci. 
Mater. Med. 2010, 21, 2227–2236. 
198. Dantas, M.D.M.; Cavalcante, D.R.R.; Araújo, F.E.N.; Barretto, S.R.; Aciole, G.T.S.; Pinheiro, A.L.B.; 
Ribeiro, M.A.G.; Lima-Verde, I.B.; Melo, C.M.; Cardoso, J.C.; et al. Improvement of dermal burn 
healing by combining sodium alginate/chitosan-based films and low level laser therapy.  
J. Photochem. Photobiol. B 2011, 105, 51–59. 
199. Liakos, I.; Rizzello, L.; Scurr, D.J.; Pompa, P.P.; Bayer, I.S.; Athanassiou, A. All-natural composite 
wound dressing films of essential oils encapsulated in sodium alginate with antimicrobial properties. 
Int. J. Pharm. 2014, 463, 137–145. 
200. Kavoosi, G.; Nateghpoor, B.; Dadfar, S.M.M.; Dadfar, S.M.A. Antioxidant, antifungal, water 
binding, and mechanical properties of poly(vinyl alcohol) film incorporated with essential oil as a 
potential wound dressing material. J. Appl. Polym. Sci. 2014, 131, doi:10.1002/app.40937. 
201. Dias, A.M.A.; Braga, M.E.M.; Seabra, I.J.; Ferreira, P.; Gil, M.H.; de Sousa, H.C. Development 
of natural-based wound dressings impregnated with bioactive compounds and using supercritical 
carbon dioxide. Int. J. Pharm. 2011, 408, 9–19. 
202. Zhao, S.; Li, L.; Wang, H.; Zhang, Y.; Cheng, X.; Zhou, N.; Rahaman, M.N.; Liu, Z.; Huang, W.; 
Zhang, C. Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate 
angiogenesis and heal full-thickness skin defects in a rodent model. Biomaterials 2015, 53,  
379–391. 
203. Joshi, M.; Butola, B.S.; Saha, K. Advances in topical drug delivery system: Micro to nanofibrous 
structures. J. Nanosci. Nanotechnol. 2014, 14, 853–867. 
204. Khajavi, R.; Abbasipour, M.; Barzi, M.G.; Rashidi, A.; Rahimi, M.K.; Mirzababa, H.H. Eucalyptus 
essential oil-doped alginate fibers as a potent antibacterial wound dressing. Adv. Polym. Technol. 
2014, 33, doi:10.1002/adv.21408. 
205. Karami, Z.; Rezaeian, I.; Zahedi, P.; Abdollahi, M. Preparation and performance evaluations of 
electrospun poly(ε-caprolactone), poly(lactic acid), and their hybrid (50/50) nanofibrous mats 
containing thymol as an herbal drug for effective wound healing. J. Appl. Polym. Sci. 2013, 129, 
756–766. 
206. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review. 
Food Chem. Toxicol. 2008, 46, 446–475. 
207. Balasubramanian, S.; Eckert, R.L. Keratinocyte proliferation, differentiation, and apoptosis—Differential 
mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol. Appl. Pharmacol. 2007, 224, 
214–219. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
